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Abstract  
Normal ovarian function is an important aspect of reproductive health, 
and loss of this function can have drastic consequences including infertility as 
well as an increased risk for diseases like ovarian cancer. The ability to 
initiate and maintain a pregnancy is dependent on the regulation of oocyte 
developmental competence, ovulation and corpus luteum function as each 
makes an important contribution to proper ovarian function. During the 
periovulatory period, ovulation is initiated as a surge of LH induces granulosa 
cells to rapidly transform from estrogen producing follicular cells to 
progesterone producing luteal cells. The molecular mechanisms involved with 
the follicular to luteal transition have been extensively studied, and many 
transcriptional changes have been associated with steroidogenic and/or cell 
differentiation pathways. Comparatively, little attention has been given to 
post-transcriptional regulatory events during this period despite such events 
having an apparent role in maintaining the integrity of gene expression. 
MicroRNA (miRNA) are highly conserved, 21nt long RNA molecules 
that offer a way to regulate gene expression at the post-transcriptional level 
by binding to the 3’UTR region of a target mRNA and either preventing its 
translation or causing its degradation. MicroRNA have been shown to be 
involved in cell differentiation in other systems implying that they may also 
have a role in the changes that occur within granulosa cells following the LH 
surge. Within this thesis, I discuss several studies designed to look at miRNA 
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expression in periovulatory granulosa cells. In addition, I describe several 
methods that can be used to measure levels of miRNA in their mature form as 
well as techniques used to begin to determine their functional relevance to the 
processes of ovulation and luteinization.  
I hypothesize that specific miRNA are induced by the LH surge, and 
that these miRNA are involved with regulating translation of specific target 
mRNA(s) within periovulatory granulosa cells. Using a mouse model, I have 
shown 13 miRNA to be differentially expressed at 4 hours post hCG, a critical 
time during the periovulatory period when many changes in gene expression 
are known to occur. MicroRNA-132 and miRNA-212 were found to be two of 
the most highly upregulated miRNA at this time point; therefore, I chose to 
narrow our examination to the characterization of these two miRNA and their 
potential mRNA targets within the periovulatory follicle. In addition to miRNA 
studies, I have also begun to look at the gene within which miRNA-132 and 
212 reside. Experiments designed to look at the expression of this gene 
suggest that it is regulated by LH as well. The results I present here provide 
the groundwork necessary for studying the function and regulation of miRNA-
132 and 212 within periovulatory follicles.
 viii 
Table of Contents 
Acceptance Page ..........................................................................................  ii 
Dedication Page ............................................................................................ iii 
Acknowledgements Page .............................................................................  iv 
Abstract ........................................................................................................  vi 
Table of Contents ........................................................................................ viii 
List of Tables and Figures .............................................................................  x 
Chapter 1: Introduction and Significance  
1. Ovulation and Luteinization .............................................................  1  
2. Post-Transcriptional Regulation and MicroRNA ..............................  4 
3. MicroRNA 132 and 212 and Their mRNA Targets ...........................  9 
4. Study Significance .........................................................................  13 
Chapter 2: Hormonal Regulation of MicroRNA Expression in  
         Periovulatory Mural Granulosa Cells  
1. Abstract .........................................................................................  15 
2. Introduction ....................................................................................  17 
3. Methods and Materials ..................................................................  20 
4. Results ...........................................................................................  31 
5. Discussion .....................................................................................  49 
Chapter 3:  Quantitative RT-PCR Methods for Mature MicroRNA  
         Expression Analysis  
1. Summary .......................................................................................  55 
2. Introduction ....................................................................................  56 
3. Materials ........................................................................................  59 
4. Methods .........................................................................................  63 
5. Notes .............................................................................................  79 
Chapter 4: Transcriptional Regulation of MicroRNA-132/212 Expression  
         in Murine Periovulatory Granulosa Cells  
1. Abstract .........................................................................................  86 
 ix 
2. Introduction ....................................................................................  88 
3. Methods and Materials ..................................................................  90 
4. Results ...........................................................................................  92 
5. Discussion .....................................................................................  96 
Chapter 5: Conclusions and Future Directions ............................................  97 
Chapter 6: References ..............................................................................  102 
 x 
List of Tables 
Table 2-1 Reverse transcription and qRT-PCR primer sequences ...  26 
Table 2-2 High abundance microRNAs .............................................  32 
Table 2-3 Intermediate abundance microRNAs ................................  33 
Table 2-4 Low abundance microRNAs .............................................  34 
Table 2-5 Ovarian transcripts with Mirn132 recognition sites ............  46 
Table 3-1 Generation of a standard curve ........................................  68 
 
List of Figures 
Figure 1-1 MicroRNA biogenesis .........................................................  7 
Figure 1-2 MicroRNA-132 & 212 in relationship to each other .............  9 
Figure 2-1 Microarray cluster analysis ...............................................  36 
Figure 2-2 In vivo qRT-PCR analysis of miRNA-132 & 212 ...............  38 
Figure 2-3 qRT-PCR analysis of microRNA processing factors .........  40 
Figure 2-4 In vitro qRT-PCR analysis of miRNA-132 & 212 ...............  42 
Figure 2-5 In vitro qRT-PCR analysis of miRNA 132 & 212  
 following LNA transfection ................................................  44 
Figure 2-6 qRT-PCR and Western blot for miRNA-132 targets ..........  48 
Figure 3-1 Schematic of methods used to reverse transcribe RNA ...  58 
Figure 3-2 Analysis of stem-loop qRT-PCR method ..........................  76 
Figure 3-3 Analysis of modified oligo (dT) qRT-PCR method ............  77 
Figure 3-4 Comparison of qRT-PCR methods ...................................  78 
Figure 4-1  AK006051 gene ................................................................  89 
Figure 4-2  Pri-miR 132/212 primer design .........................................  91 
Figure 4-3  qRT-PCR analysis of pri-miR-132/212 expression ...........  94 
Figure 4-4  qRT-PCR analysis of AK006051 expression ....................  95 
 1 
Chapter 1 
Introduction and Significance 
 
Ovulation and Luteinization 
The two main functions of the mammalian ovary are to produce 
competent oocytes and steroid hormones. The processes of ovulation and 
luteinization are regulated by a multi-tiered negative feedback system that 
involves gonadotropins produced by the hypothalamus and pituitary as well 
as hormones synthesized within the granulosa and theca cells of ovarian 
follicles. A surge of luteinizing hormone (LH) is the initiating factor for the 
processes of ovulation and luteinization [1-3].  
In response to the LH surge, luteinization of mural granulosa cells 
begins prior to ovulation and results in their transformation from a follicular 
estrogen producing cell to a luteal progesterone producing cell. To 
accomplish these phenotypic and functional changes, several things occur 
including exit from the cell cycle, external signal response modifications, as 
well as alterations in gene expression and signal transduction pathways. Cells 
typically cycle between proliferative and quiescent states in a process that is 
mediated by cyclins D and E which are regulated by cyclin-dependent kinases 
(Cdk) [4]. This process is thought to be regulated by Cdk inhibitors p21Cip1 
and p27Kip1 [5]. The LH surge has been shown to rapidly inhibit cyclin D2 
while simultaneously inducing expression of both p21Cip1 and p27Kip1 [6, 7]. 
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Together, these events are thought to be associated with the loss of cell cycle 
regulation that culminates in the absence of GC proliferation during 
luteinization. Interestingly, knockout studies have shown that GC proliferation 
is not changed in p21Cip1 -/- animals, while GC undergo a hyperproliferative 
state following the LH-surge in p27Kip1 -/- animals [8]. These results indicate 
that p27Kip1 may have a vital role in LH-induced GC cell cycle arrest during 
luteinization. 
One of the main signaling pathways in LH-induced granulosa cell 
differentiation involves the second messenger cAMP [9]. Binding of LH to LH 
receptors on the cell surface of granulosa cells initiates a signal transduction 
cascade that leads to the activation of cyclic-AMP-dependent protein kinase 
(PKA) and the phosphorylation of CRE-binding (CREB) protein. This results in 
the altered expression patterns of many genes associated with ovulation, 
cumulus expansion and establishment of the corpus luteum [10].  For 
example, changes in the expression of progesterone receptor (PR) and 
peroxisome proliferator-activated receptor gamma (PPARγ) are associated 
with ovulatory events [11, 12], while cumulus expansion is mediated by the 
induction of epidermal growth factor (EGF)-like factors epiregulin and 
amphiregulin [13]. These factors have been shown to induce the expression 
of prostaglandin synthase 2 (Ptg2) and human hyaluronan synthase 2 (Has2), 
genes involved with extracellular matrix remodeling [13]. Failure to ovulate in 
connexin-37 [14], Ptg2 [15], CCAAT/enhancer binding protein-β (Cebp-β) [16] 
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and progesterone receptor (Pgr) [11] knock out animals indicates the 
importance of many factors in the ovulatory process and suggests that it is a 
highly regulated event. 
Formation of a functional corpus luteum (CL), an endocrine gland 
derived from the granulosa and theca cells of an ovulated follicle, is 
necessary for the establishment of pregnancy and regulation of the estrous 
cycle [17, 18]. During the period following the LH surge, granulosa cells 
undergo cell cycle arrest, increase in volume, and begin to fill with lipid 
droplets [19]. Studies have shown that luteinizing granulosa cells also 
undergo many changes in gene expression including increases in the 
expression of scavenger receptor type I, class B (SR-B1) and steroidogenic 
acute regulatory protein (StAR) [17], factors involved with cholesterol 
transport and metabolism. Additionally, the switch from estrogen to 
progesterone production in LH stimulated granulosa cells is supported by 
increases in the expression of steroidogenic enzymes like cholesterol side 
chain cleavage cytochrome P450 (CYP11A) [20, 21] and 3-β-hydroxysteroid 
dehydrogenase (3β-HSD) [22] as well as by a decrease in the expression of 
aromatase [23]. While numerous studies have provided us with important 
information related to transcriptional regulatory mechanisms that occur within 
granulosa cells following the LH surge, other mechanisms of gene regulation 
occur following transcription. These post-transcriptional regulatory 
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mechanisms are critical for gene expression and are vital to proper tissue and 
organ function. 
Post-Transcriptional Regulation and MicroRNA 
Upon initiation of transcription, a number of post-transcriptional control 
mechanisms are in place to provide a regulatory network which allows 
mRNAs to be packaged, transported, sequestered and/or destroyed prior to 
being translated into a protein thus controlling the amount of gene product 
made into a protein. Regulatory events such as alternative splicing, RNA 
editing and nuclear transport blockage are often mediated by RNA-binding 
proteins (RBPs) and occur within the nucleus [10], while other RBP and non-
coding RNA mediated mechanisms take place within the cytoplasm [24].  
RBPs are trans-acting factors that bind to cis elements located within 
the 3`untranslated region (3`UTR) of specific messages and mediate 
transcript localization within the cytoplasm, as well as mRNA stabilization, 
translation and degradation [24, 25]. Regulatory specificity is maintained by 
sequence elements within the 3`UTR. One of the best studied sequence 
element is the A+U-rich element (ARE), known to be a strong destabilizing 
element as transcripts containing this structure within their 3`UTR display 
increased rates of decay [26].  For example, the protein AUF1 mediates 
mRNA destabilization when bound to the ARE. In contrast, ARE-binding of 
He1-N1, HuC, HuD and HuR proteins has been associated with mRNA 
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stabilization [26] indicating a complex regulatory network for ARE containing 
transcripts.  
MicroRNAs (miRNAs), another type of trans-acting factor, are 
endogenous ~21nt long non-coding RNA molecules that bind specifically to 
the 3` UTR region of their target mRNAs and prevent translation [27]. They 
are predicted to constitute ~1% of the entire human genome and are perhaps 
responsible for regulating up to one third of all mRNA [28, 29]. Sequences for 
these small regulatory RNA molecules have been located throughout the 
genome and include intergenic, exonic and intronic regions of the DNA [30] 
with more than 3,000 miRNAs having currently been identified in species 
ranging from plants to humans [28].  
Processing of miRNAs occurs in a series of steps (Figure 1-1) 
beginning with the synthesis of a 5` capped and polyadenylated [31] primary 
miRNA (pri-miRNA) [32, 33]. Pri-miRNAs are cleaved by the RNase III 
endonuclease Drosha which works in combination with the co-factor DGCR8 
to produce a ~60-70 nucleotide (nt) stem-loop intermediate precursor miRNA 
(pre-miRNA) that contains a ~2nt 3` overhang at the Drosha cleavage site 
[34, 35].  Drosha’s endonuclease activity is specific to double stranded RNA 
and has been found to be ~11 base pairs from the junction between the stem-
ssRNA of the pri-RNA structure. [36, 37].  Following Drosha cleavage, the 
pre-miRNA stem-loop structure is exported from the nucleus to the cytoplasm 
by Exportin-5 through a Ran-GTP mechanism [38-40] where it is then cleaved 
 6 
by Dicer, another RNase III endonuclease. Dicer binds to a region of the pre-
miRNA at the base of the stem-loop and cuts both stands of RNA to produce 
a 3` ~2nt overhang on the opposite strand from the overhang produced by 
Drosha [33]. This imperfect double stranded RNA duplex is referred to as 
miRNA:miRNA* with the miRNA portion referred to as the guide (mature) 
strand and the miRNA* portion as the passenger (non-functional) strand [41]. 
The miRNA:miRNA* duplex, which is believed to be a transient structure [42], 
is then preferentially loaded onto the RNA-induced silencing complex (RISC), 
a structure composed of Dicer, Argonaute proteins, and other RISC 
associated factors [43]. The strand loaded onto RISC is thought to be the one 
with the less stable 5` end, while the other strand (typically the miRNA* 
strand) undergoes degradation [44, 45]. Interestingly, recent data has shown 
the existence of functional miRNA on both the 5` and 3` arms for the hairpin 
pre-cursor; therefore, new convensions for naming these types of functional 
miRNA include the addition of -5p or -3p to the end of the miRNA notation 
[46]. 
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Figure 1-1 
 
 
FIGURE 1-1: Graphical representation depicting the process of microRNA synthesis 
and target recognition. 
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There appear to be two main mechanisms by which miRNAs impose 
translational regulation on their specific mRNA target(s): repression and 
cleavage/degradation [28]. The 2-8 position at the 5` end of the mature 
miRNA, referred to as the seed sequence, is considered to be very important 
to target recognition [47, 48]. It is the most conserved region of mammalian 
miRNA [42, 47] and has been shown to be a reliable way to predict targets 
based on perfect complementary pairing [47]. The determining factor as to 
whether a mRNA will follow a degradation pathway versus a repression 
pathway appears to be related to the degree of complementary base pairing 
that occurs within the 3`UTR. The more perfect the pairing, the more likely the 
mRNA will be cleaved and degraded [49-51]. This is often the case in plants 
[52, 53], while mammalian miRNAs typically display less than perfect base 
pairing with the 3`UTR of their targets [50, 54]. 
Currently, very little is known about the specific targets for most of the 
identified miRNAs, therefore the functional aspects of specific miRNAs 
continue to remain largely elusive [27]. Experimental validation has linked 
only a handful of miRNAs to a target and/or function [28]. For example, many 
of the biological roles of miRNAs in nematodes are related to temporal 
regulation of development [54-58]. Similarly, miRNA function in plants also 
appears to relate largely to developmental processes [53, 59, 60]. In other 
species, the role miRNAs play appears to be much more diverse. In 
Drosophila, miRNAs have been shown to control aspects of both cell 
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Murine Chromosome 11
Pre miRNA-212 Pre miRNA-132
 204 nt 
CRE SiteCRE Sites
 
 
FIGURE 1-2: Depiction of miRNA-132 and 212 in relation to each other on 
mouse chromosome 11. 
proliferation and differentiation. For example, the bantam miRNA has been 
found to target the message for the pro-apoptotic gene hid, and thus affect an 
apoptotic pathway critical to fly development [48]. Furthermore, mammalian 
miRNAs have been shown to regulate cell growth by acting through a cAMP 
regulated pathway [61] and have been associated with many other processes 
including cell cycle regulation, differentiation, apoptosis, oncogenesis and 
tumor suppression [27]. 
 
MicroRNA 132 and 212 and Their mRNA Targets 
The pre-forms of microRNA-132 and 212 are situated 203 nucleotides 
apart from each other on chromosome 11 of the mouse genome (Figure 1-2) 
within the first intron of a three exon gene (AK006051) that encodes a 
transcript of unknown function. MicroRNA-132 and 212 share the identical 
seed sequence (AACAGUC) and contain cAMP regulatory element (CRE) 
sequences immediately 5` of the sequence that codes for their mature forms. 
This would suggest that CREB, a transcription factor known to bind to CREs, 
may bind to and regulate miRNA-132 and 212 expression [61]. This is 
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interesting as the cAMP pathway is thought to be one of the main signal 
transduction cascades induced by LH during the luteinization of granulosa 
cells [9, 62].  
One of the experimentally validated targets of miRNA-132 is p250GAP. 
Also known as p200RhoGAP/Grit and RICS [63], p250GAP is a RhoGTPase 
activating protein that has been linked to dendrite differentiation [61, 64]. Rho 
GTPases are made up of six different classes (Rho, Rac, Cdc42, Rnd, RhoD, 
and TTF) and are involved in the initiation of signal transduction pathways 
that result in cellular processes like vesicle trafficking, cytoskeletal 
reorganization, as well as cell cycle and transcriptional regulation [65], all of 
which are integrally related to the process of differentiation. RhoGTPases act 
like molecular switches flipping from an active (GTP bound) state to an 
inactive (GDP bound) state [66, 67]. Their hydrolytic activity is stimulated by 
GTPase-activating proteins (GAPs) which mediate cleavage of a phosphate 
group from the GTP molecule resulting in signal transduction cascade 
changes [68]. Recently, Vo et al. [61] showed that over-expression of miRNA-
132 in a neuronal cell line resulted in a reduction of p250GAP, thus validating 
it as a target. Inhibition of RhoGAP was also shown to cause an increase in 
dendrite outgrowth, which was identical to the response seen when miRNA-
132 was over-expressed in the same cell line [61].  
Much of the work done with p250GAP has been in neuronal tissue, 
where RhoGTPase activation by RhoGAPs has been associated with actin 
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stress fiber formation [69] and changes in oligodendrocyte cell morphology 
[65]. More specifically, RhoGTPase has been shown to reduce the number of 
dendrite spines [70] via a microtubule based mechanism [71] which promotes 
the retraction of the cell membrane [66]. In addition to neuronal tissue, 
p250GAP has also been shown to be expressed in the human ovary [72], and 
the worm homolog (RRC-1) is known to co-localize to the uterine-seam cells 
in C. elegans [73]. Given the role RhoGTPases have in the control of cell 
morphology within neuronal cells, it is appealing to consider the possibility of 
a connection between miRNA-mediated regulation of p250GAP and the 
morphological changes that occur during luteinization. 
Two additional experimentally validated targets of miRNA-132 are 
methyl CpG binding protein 2 (MeCP2) and C-terminal binding protein 1 
(CtBP1). Klein et al (2007) have shown that these two proteins are regulated 
by miRNA-132 and are involved with a feedback loop responsible for 
maintaining homeostatic levels of MeCP2, a protein known to play an integral 
role in dendrite differentiation within the nervous system [74]. MeCP2 is part 
of a family of proteins involved with epigenetic regulation. This protein is 
known to inhibit transcription by both binding to 5`CpG3` pairs that are 
symmetrically methylated and recruiting corepressor complexes to the DNA 
resulting in signal transduction changes that alter gene expression [74, 75]. 
Rett syndrome, an X-linked disease characterized by nervous system 
developmental defects associated with mental retardation, is known to be 
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caused by mutations in the MECP2 gene. Interestingly, neurological 
deficiencies associated with this disease are diminished in a mouse model 
following the re-establishment of MeCP2 protein levels thus validating the link 
between MeCP2 and this disease [75].  
Similar to MeCP2, CtBP1 is known as a regulator of transcription and 
also interacts with many transcription factors [76]. Although initially identified 
as a transcriptional activator of the adenovirus E1A oncoproteins, CtBP1 is 
primarily associated with transcriptional repression [76]. As expected, studies 
have shown the function of many transcription factors to be disrupted in 
CtBP1 deficient mice [77]. A recent study has discussed a possible role for 
CtBP1 in the regulation of CYP17 expression within adrenocortical cells [78]. 
Although CYP17 is not expressed within pre-ovulatory GCs, CtBP1 has been 
shown to interact with and alter the ability of steroidogenic-factor 1 (SF-1) to 
stimulate promoter activity. This is interesting as SF-1 is thought to be 
involved with regulating the expression of many genes within granulosa cells 
[79]. In addition to its transcriptional regulatory activities, CtBP1 has a 
potential link to cytoskeletal activities (including microtubule dynamics) as it is 
known to bind to PDZ domain proteins responsible for anchoring 
transmembrane proteins to cytoskeletal components within the cytosol [76]. 
Given the diverse functional roles of MeCP2 and CtBP1, as they relate to 
gene expression and cytoskeletal dynamics, combined with the dynamic 
nature of granulosa cell transcription and phenotypic activity during the 
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periovulatory period, it is not improbable to speculate that these two proteins 
could play an integral role in the processes of ovulation and luteinization. 
 
Study Significance 
Women’s reproductive health care is an area of increasing research 
interest and proper ovarian function plays a significant role in both 
reproductive ability and the overall health of an individual. The importance of 
normal ovarian function is highlighted by the number of women who 
encounter difficulties achieving pregnancy. Infertility, defined as the inability to 
get pregnant following a one year trial period, affects millions of women each 
year as suggested by the incidence of infertility-related appointments 
scheduled by 2% of women of reproductive age. In addition to fertility issues, 
the reproductive health of women can be compromised by diseases like 
Polycystic Ovarian Syndrome (PCOS) and ovarian cancer. PCOS, a treatable 
disease associated with high androgen levels, abnormal follicle growth, 
hirsutism and affects 5-10% of women of child-bearing age in the United 
States [80]. This disease is non-fatal but is associated with a high incidence 
of infertility as well as other non-reproductive symptoms including insulin 
resistance, obesity and high-blood pressure. In contrast, ovarian cancer is the 
most fatal of all female reproductive tract cancers undoubtedly due to a lack 
of early detection. Typically originating from epithelial cells lining the outer 
surface of the ovary, more than 21,000 women are diagnosed with ovarian 
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cancer each year; furthermore, this disease is responsible for more than 
15,000 deaths annually [81]. These major reproductive health issues suggest 
the need for more knowledge about the mechanisms involved with 
maintaining proper ovarian function. 
The recent discovery of miRNA offers the prospect of new and exciting 
post-transcriptional regulatory mechanisms that may play an integral role in 
the maintenance of normal cellular processes during the follicular and luteal 
phases of the ovarian cycle. A growing body of evidence has linked miRNA to 
cell transformation processes as well as tumorigenesis, but the mechanisms 
by which miRNAs cause these outcomes are poorly understood. The 
experiments within this thesis represent a starting place and will provide a 
sound basis for future studies into the role miRNA play in ovarian granulosa 
cell function. They will also establish the basic methodological tools that will 
be essential for dissecting the role of miRNA in ovarian function. 
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Chapter 2 
Hormonal Regulation of MicroRNA Expression in 
Periovulatory Mural Granulosa Cells 
 
ABSTRACT 
MicroRNAs (miRNA) mediate post-transcriptional gene regulation by 
binding to the 3’untranslated region of messenger RNAs to either inhibit or 
enhance translation. The extent and hormonal regulation of miRNA 
expression by ovarian granulosa cells and their role in ovulation and 
luteinization is unknown. In the present study, miRNA array analysis was 
used to identify 212 mature miRNAs as expressed and 13 as differentially 
expressed in periovulatory granulosa cells collected before and after an 
ovulatory surge of hCG. Two miRNAs, Mirn132 and Mirn212 (also known as 
miR-132 and miR-212), were found to be highly upregulated following 
LH/hCG-induction and were further analyzed. In vivo and in vitro temporal 
expression analysis by quantitative RT-PCR confirmed that LH/hCG and 
cAMP, respectively, increased transcription of the precursor transcript as well 
as the mature miRNAs. Locked nucleic acid oligonucleotides complementary 
to Mirn132 and Mirn212, were shown to block cAMP-mediated mature miRNA 
expression and function. Computational analyses indicated that 77 putative 
mRNA targets of Mirn132 and Mirn212 were expressed in ovarian granulosa 
cells. Furthermore, upon knockdown of Mirn132 and Mirn212, a known target 
of Mirn132, C-terminal binding protein 1, showed decreased protein levels but 
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no change in mRNA levels. The following studies are the first to describe the 
extent of miRNA expression within ovarian granulosa cells and the first to 
demonstrate that LH/hCG regulates the expression of select miRNAs, which 
affect post-transcriptional gene regulation within these cells. 
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INTRODUCTION 
 Ovulation of a mature and viable oocyte and the formation of a 
functional corpus luteum (CL) are essential for establishment of pregnancy. 
These events are preceded by a highly orchestrated series of growth and 
developmental events in the periovulatory follicle that ultimately signals the 
preovulatory surge of luteinizing hormone (LH) resulting in the initiation of 
ovulation and CL formation [1-3]. Numerous studies have shown that the LH 
surge initiates the transcriptional up and down regulation of genes, including 
cytokines, transcription factors, and matrix-remodeling proteins within 
periovulatory granulosa cells [6, 82, 83]. Furthermore, the signaling 
mechanisms whereby the LH receptor transduces this endocrine signal within 
ovarian granulosa cells is well described [9, 84, 85]. However, post-
transcriptional gene regulation with respect to ovarian function [86], outside of 
oocyte development [87], has been largely overlooked. The recent 
identification of microRNAs (miRNAs) within somatic tissues, in particular 
rapidly differentiating cells such as embryonic tissues and cancer cells, has 
implicated post-transcriptional gene regulation as a central player in 
development [27, 88-90]. In the adult animal, the cyclic phenotypic changes 
that take place in the ovary and uterus are some of the more dramatic cellular 
and tissue changes to occur outside of embryonic development. The 
structural and functional transformation that takes place as the highly prolific 
periovulatory follicular granulosa cells terminally differentiate into luteal cells 
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occurs exceptionally fast and requires a complete change in the cellular 
phenotype. The importance of transcription in this conversion is highlighted by 
the marked number of genes that are transcriptionally regulated during this 
period [91-93] and by the essential role specific LH-induced genes (e.g. 
progesterone receptor, CCAAT/enhancer binding protein β, prostaglandin 
synthetase-2, cyclin D2 [7, 11, 15, 16]) have on the processes of ovulation 
and luteinization. No singular method has allowed for the global evaluation of 
post-transcriptional gene regulation as it pertains to ovarian granulosa cell 
function; nonetheless, it is relatively easy to envision that during the 
phenotypic transformation of the granulosa cells, follicular transcript turnover 
and/or the blockade of follicular transcript translation would facilitate the 
processes of ovulation and luteinization. MicroRNAs provide such a post-
transcriptional mechanism whereby large classes of transcripts may be 
simultaneously and effectively regulated by individual factors [94].       
 MicroRNAs are highly conserved, ~21nt long RNA molecules that post-
transcriptionally regulate the expression of specific mRNAs or groups of 
mRNAs based on interactions with the 3’untranslated regions (UTR) of 
specific mRNAs [27]. MicroRNAs are initially transcribed as pri-miRNAs, can 
be several kilobases in length and contain a characteristic hairpin loop 
structure [33, 95]. These pri-miRNA transcripts are cleaved by the RNase III 
endonuclease Drosha which works in combination with its co-factor DGCR8 
to produce a ~70 nucleotide stem-loop intermediate precursor miRNA (pre-
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miRNA) [40]. Following Drosha cleavage, the pre-miRNA stem-loop structure 
is exported from the nucleus to the cytoplasm by Exportin-5 through a Ran-
GTP mechanism [38] where it is then cleaved by Dicer to produce the mature 
form of the miRNA [33]. The mature miRNA harbors a sequence of 7 
nucleotides known as the seed sequence (bases 2-8 of the miRNA), a region 
that binds to the 3’UTR of target mRNAs. This mature miRNA, in association 
with the RNA induced silencing complex, effectively blocks the process of 
translation and/or causes the degradation of the targeted mRNAs [47, 96]. 
Moreover, recent observations of Vasudevan et al. [97] illustrate that miRNAs 
can differentially regulate translation, inhibiting under conditions of active cell 
proliferation and promoting under conditions of cell cycle arrest. Despite 
having been shown to be involved with proliferation and cell differentiation in 
a variety of systems [27, 98, 99], the role of miRNAs within periovulatory 
granulosa cells is presently unknown. In the following set of experiments, we 
have identified several hormonally regulated miRNAs within periovulatory 
granulosa cells. Additionally, we have examined the expression of the two 
most significantly upregulated miRNAs and have begun to identify 
downstream targets that may establish their potential role during the 
processes of ovulation and luteinization. 
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METHODS AND MATERIALS 
Animals and Granulosa Cell Isolation 
Nineteen-day old CF-1 female mice were injected i.p. with 5IU eCG to 
induce follicular stimulation. After 46 hours, the ovaries were either collected 
(0 hour time point) or the mice were injected i.p. with 5IU of hCG and ovaries 
collected at 1, 2, 4, 6, 8 and 12 hours post-hCG. Follicles were punctured with 
a 30-gauge needle and granulosa cells were collected into ice-cold PBS 
[100]. Mural granulosa cells were separated from cumulus oocyte complexes 
using a 50 µm Nitex size exclusion filter (Wildlife Supply Company, Buffalo, 
NY). The mural granulosa cells were then pelleted by centrifugation (770 x g) 
and resuspended in 500 µL of TRI Reagent for subsequent RNA extraction as 
per manufacturer’s protocol (Sigma, St. Louis, MO). To obtain proliferating 
granulosa cells for in vitro culture, ovaries from 25-27 day old unprimed 
female CF-1 mice were collected into room temperature M-199 medium 
(Sigma) supplemented with 10 mM Hepes (Gibco, Carlsbad, CA) and 0.2% 
bovine serum albumin (Sigma). Ovaries were then transferred to M-199 
media containing 1.8 mM EGTA and 0.5 M sucrose (Fluka, St.Louis, MO) and 
incubated for 15 minutes at 37°C. Following incubation, ovaries were rinsed 
three times in M-199 media to remove sucrose then were punctured as 
previously described. Expressed mural granulosa cells were centrifuged for 5 
minutes, resuspended in Dulbecco Modified Eagle medium/ Ham F-12 
(DMEM/F-12; Cellgro, Manassas, VA) supplemented with 10% heat 
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inactivated fetal bovine serum (Atlanta Biologicals, Lawrenceville, GA) and 
1% Gentamicin (Gibco). All procedures involving animals were reviewed and 
approved by the University Committee on the Use and Care of Animals at the 
University of Kansas Medical Center and performed in accordance with the 
Guiding Principles for the Care and Use of Laboratory Animals. All 
experiments were performed using CF-1 female mice from Charles River 
Laboratories, Wilmington, MA.   
 
Microarray and Temporal Expression Analysis 
 Total RNA was quantified using a NanoDrop-1000 spectrophotometer 
(NanoDrop Technologies, Wilmington, DE) and quality was accessed by 
analysis of the 18S and 28S peaks on an Agilent 2001 Bioanalyzer (Agilent 
Technologies, Santa Clara, CA). Three independent replicates of mural 
granulosa cells were collected before hCG (0 hour) and 4 hours post-hCG for 
detection of mature miRNA expression by microarray analysis. The 0 hour 
granulosa cell samples were labeled with Cy3 and the 4-hour hCG samples 
with Cy5. Each 0 and 4-hour replicate was then hybridized as a pair onto an 
individual Atactic µParaFlo microfluidics chip (Sanger versions 8.2 and 9.0 
[101, 102]; LC Sciences, Houston, TX) as described in detail by the 
manufacturer. These chips (n=3) included 357 experimentally validated 
miRNAs on the 8.2 Sanger chip and 375 on the version 9.0 chip. An 
additional 100 miRNAs predicted in human but not detected/represented in 
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the murine miRNA 8.2/9.0 Sanger databases were also printed onto the 
microarray chips to evaluate their expression in periovulatory granulosa cells 
(list provided upon request). This data was normalized using a cyclic 
LOWESS (Locally-weighted Regression) method as described by LC 
Sciences, Inc, to remove system related variations such as sample amount 
variations, dye labeling bias, and signal gain differences between scanners. 
Those signals that were greater than background plus three times the 
standard deviation were then derived for each color channel; the mean and 
the co-variance (CV = st. dev. x 100/replicate mean) was calculated for each 
probe having a detected signal. A log transformed ratio was then calculated 
from the two sets of detected signals, and the transcript ratios with p-values of 
less than 0.01 were considered to be differentially expressed. For clustering 
analysis of multiple datasets, data adjustment included data filtering, Log2 
transformation, and gene centering and normalization. Data filtering was also 
done to remove clustering values from the data set (detected signals or 
detected ratios below a threshold value). An in-depth cluster analysis was 
then completed using the paired samples, and differentially expressed 
transcripts were compiled (p-value < 0.05). Lists of miRNAs showing their 
relative fluorescence values were generated after exclusion of all transcripts 
that failed to be present in two of three 0 hour and two of three 4 hour 
samples and those having fluorescence values of less than 50, which is 
approximately half of the background level. Additionally, the normalized and 
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background subtracted data was analyzed using the National Institute of 
Aging Array Analysis (http://lgsun.grc.nia.nih.gov/anova/) with significant 
genes identified as having  p-values < 0.05 [103].  
   
Quantitative RT-PCR for Mature miRNAs 
 Quantitative RT-PCR (qRT-PCR) was performed to validate the 
microarray results and to analyze the temporal expression of specific mature 
miRNAs. Human miRNA assay kits for specific miRNAs (mmu-miR-132, 
mmu-miR-212, mmu-miR-21, and mmu-miR-31 hereafter referred to Mirn132 
and Mirn212, etc.) were purchased from Applied Biosystems (Foster City, CA) 
as were the reverse transcription kits. Total RNA was diluted to a 50 ng/ul 
working dilution then 250 ng were used in the RT reactions following the 
manufacturer’s protocol with the following modifications. Briefly, 3 to 5 
miRNAs were reverse transcribed in a single RT reaction using 2 ul of each 
miRNA specific 5x RT primer. This single RT reaction for multiple miRNAs 
then served as the starting material for independent qRT-PCR reactions using 
the primers and probes specific to each miRNA. In addition to the added 
benefit that only one fifth of the reverse transcription reagents and RNA were 
needed, a single reaction allowed the normalizer and target amplicons to be 
determined from the same RT reaction. Comparison of the qRT-PCR results 
for miRNAs that were reverse transcribed as a group versus those that were 
transcribed individually showed no differences, indicating that the RT primers 
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and the derived cDNAs do not interfere with the quantification of the other 
miRNAs. To normalize for starting material, a 20 ul aliquot from each of the 
50 ng/ul total RNA sample dilutions was reverse transcribed using random 
hexamers and GAPDH levels determined using the Rodent GAPDH Taqman 
primers and probe (Applied Biosystems). Additionally, a reverse snRNA U6 
RT/PCR primer (see Table 2-1 for sequence) was included in some of the 
miRNA RT reactions and qRT-PCR of U6 (Table 2-1) following either miRNA 
RT or random hexamer RT demonstrated that GAPDH and U6 were equally 
valid for normalization (results not shown). Comparison of the qRT-PCR 
results using GAPDH, U6 snRNA or miR31 (miR31 was shown not to change 
in granulosa cells following in vivo LH treatment) as the normalizer made no 
difference in the relative profiles of the target miRNAs. As most of the initial in 
vivo studies used GAPDH, we chose to depict all of the data normalized to 
GAPDH levels for consistency throughout the paper. The qRT-PCR reactions 
were completed on the 7900 HT Sequence Detection System (Applied 
Biosystems). Each sample was run in triplicate, and the average used in 
subsequent calculations. Each primer set included a minus RT control. The 
delta-delta Ct method was used to calculate relative fold-change values 
between samples [104], and at least three independent replicate experiments 
were used to calculate means and SEM values.  
 
Quantitative RT-PCR for primary-miRNAs and Messenger RNAs 
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 To confirm that a single pri-miRNA exists for Mirn132 and Mirn212 and 
that it is transcriptionally upregulated in response to LH, a qRT-PCR primer 
set was designed to amplify a region that spans from the 5’ end of the 
Mirn212_pre through the 3’ end of the Mirn132_pre. These primers to the 
primary Mirn132/212 (Mirn132/212_pri; also known as pri-miR-132/212) 
transcript (see Table 2-1 for primer sequences) amplify a 349 base pair 
amplicon that was confirmed by sequencing (data not shown).  
 Intron spanning primers for Drosha, DGCR8, Exportin-5, Dicer1, 
Methyl CpG binding protein (MeCP2), C-terminal binding protein 1 (CtBP1) 
and p250 GTPase activating-protein (GAP) (also known as Grit within the 
murine genome) were designed using the Primer Express 3.0 software 
(Applied Biosystems), and qRT-PCR was conducted as previously described 
(primer sequences provided in Table 2-1)
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TABLE 2-1: Primer sequences for reverse transcription and qRT-PCR. 
 
r: aggtcgcccctgatctgat
f: cagctctggaccataacacaattgDicer1
r: tgtcttcatttgttggtacttgtttaca
f: gacgcagaacatggaaagaatctXpo5 
r: gaggcaccaaaaggctcactt
f: tcaaggtccgccctgtttatDGCR8
r: atcattgcatgctgacagacatc
f: gaagtcaccgtggagctgagtaRnasen
r: cattagggtccaaggaggtgtct
f: ttgatcaatccccagggaaaMeCP2
r: gcacactgcgatgcctagatc
f: ggcagcgggtttgacaataCtBP1
r: tatatcccatccacaatgccatac
f: ttgaagtgccccaggttcttGrit
r: gggcgaccatggctgtag
f: cggcaccttggctctagactPri-Mirn132/212 
r: aacgcttcacgaatttgcgt
f: ctcgcttcggcagcacasnRNA U6 qRT-PCR
r: aacgcttcacgaatttgcgtsnRNA U6  RT-PCR
Primer Sequence (5`->3`)Gene Name
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Granulosa Cell Culture 
 Ovarian granulosa cells expressed from 25-27 day old mouse ovaries 
as previously described were seeded at 2.5x104 cells per well into 6-well 
tissue culture plates (Corning) for temporal miRNA expression analysis and 
for anti-miRNA/locked nucleic acid (LNA) analysis or at 1x106 cells per 10 cm 
tissue culture dishes (Corning) for Western analysis. All tissue culture plastics 
were pre-coated with fibronectin (2.5ul/ml) for 30 minutes at 37°C prior to 
plating cells. Cells were cultured at 37°C in an incubator supplemented with 
5% CO2, and media was replaced 24 hours after plating to remove any 
unattached cells.  At 48 hours post-plating, the cells were placed in serum-
free DMEM/F-12 media for 24 hours at which point they were treated with 1 
mM 8-bromo-cAMP (Sigma) for 1, 2, 4, 6, 8 or 12 hours or remained 
untreated (serum-free media) for the same time periods. Total RNA was 
isolated, and expression of Mirn132 and Mirn212 were analyzed using qRT-
PCR. 
 
Transfection 
Transfection of the mural granulosa cells with anti-microRNAs (anti-
miRs) and LNA oligoribonucleotides to Mirn132 and Mirn212 was completed 
with Lipofectamine 2000 (Gibco) as described in the manufacturer’s 
instructions. Briefly, isolated mural granulosa cells were grown for 48 hours 
prior to transfection, rinsed twice with serum-free DMEM/F12 and transfected 
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with a non-specific anti-miR negative control (42nM) or with hsa-miR-132 anti-
miR (21nM) and hsa-miR-212 anti-miR (21nM; Ambion) individually or in 
combination. The anti-miR to Mirn212 failed to consistently block the Mirn212 
action and/or detection of the mature miRNA transcript. Therefore, we 
designed a set of LNA knockdown probes complementary to Mirn132 
(tggctgtagactgtta, underlined bases denote the LNA nucleotides) and Mirn212 
(tgactggagactgtta). Cells were transfected with non-specific LNA-scramble 
(40nM, IDT) or with a combination of Mirn132-LNA (20nM) and Mirn212-LNA 
(20nM). Transfection efficiency within this cell type was analyzed using a 
fluorescein-labeled BLOCK-iT Fluorescent Oligo (Invitrogen) transfected at 
100nM into cultured granulosa cells using the same protocol as stated above, 
and the transfection efficiency was determined to be 70% using fluorescent 
microscopy. Following a 24-hour transfection, the cells were rinsed twice with 
serum-free DMEM/F-12 then treated with 1mM 8-bromo-cAMP for 24 hours. 
Total RNA was isolated and miRNA expression analyzed by qRT-PCR as 
previously described.  
 
Western Blots 
Protein for Western blot analysis was collected from cAMP treated 
granulosa cells transfected with either the non-specific scramble LNA or with 
the combination of Mirn132-LNA and Mirn212-LNA then treated with 8-Br-
cAMP for 24 hours. Following treatment, granulosa cells were collected in cell 
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lysis buffer (200 µl/10cm dish; Cell Signaling Technology, Danvers, MA), and 
protein levels were quantified using the Becton Dickinson Protein Assay 
(Hercules, CA). Standard Western blot protocols were used with anti-CtBP1 
(1:1000, BD Biosciences) and anti-nucleoporin (1:500, BD Biosciences) 
antibodies diluted in TBST+5% BSA. Secondary HRP-conjugated antibodies 
were diluted in TBST+5% milk at 1:5000 for CtBP1 and nucleoporin detection. 
CtBP1/nucleoporin blots were exposed using pico ECL detection (Thermo 
Scientific). 
 
Steroid Assays 
 Concentrations of estradiol and progesterone in granulosa cell culture 
media were analyzed by radioimmunoassay as previously described [105]. 
Estradiol levels were quantified in one ml of media following ether extraction, 
while progesterone levels were measured following a 1:10 dilution of the 
medium in 0.1M PBS + 0.1% gelatin.  
  
miRNA Bioinformatics  
 To determine if mRNAs expressed within periovulatory granulosa cells 
might be regulated by LH-regulated miRNAs, a comprehensive list of Mirn132 
and Mirn212 target transcripts was created using the PicTar algorithm [106]. 
We then compared this list of transcripts to two mRNA gene lists that included 
all genes that were marginal or present within murine granulosa cells at 0 and 
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1 hour post-hCG or at 8 hours post-hCG based on Affymetrix gene chip 
analysis. The resulting list of mRNA transcripts found to be predicted targets 
of Mirn132 and Mirn212 and to be expressed within granulosa cells was then 
compared to two additional miRNA target prediction algorithms (miRBase and 
miRanda) [46, 107]. A detailed description of the computational procedures 
used to compare these lists is available upon request.   
 
Statistical Analysis 
 Three independent microarray replicates were analyzed using an 
unpaired Student’s t-test (LC Science). Statistical analysis of qRT-PCR data 
was performed with GraphPad Prism (version 4). All data were examined for 
heterogeneity of variance using Bartlett’s test. If heterogeneity of variance 
existed, the data were log transformed and analyzed via one-way ANOVA. 
Upon determination of a significant (p<0.05) F-test, Newman-Keuls Multiple 
Comparison tests were used to determine differences among the means. P-
values of less than 0.05 were considered significant. 
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RESULTS 
Identification of miRNAs Expressed within Mural Granulosa Cells 
Microarray analysis of miRNA expression in mural granulosa cells 
revealed that 196 and 206 detectable transcripts were present at 0 and 4 
hours respectively in 2 of 3 samples (n=3). Each miRNA transcript was 
arbitrarily categorized into a group based on its fluorescence, a value 
indicative of its relative level within the cells. Tables 2-2, 2-3 and 2-4 list the 
highly abundant (n=31, fluorescence ranging from 50,000 to 10,000), 
intermediate (n=64, fluorescence less than 10,000 to 1000) and low (n=117, 
fluorescence less than 1000 to 50) abundance miRNAs.  
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1917131AGGGATCGCGGGCGGGTGGCGGCCThsa-mir-638
717370GGGGCTGGGGCCGGGACAGAGCmmu-miR-762
824913GGAGGCAGAGGCAGGAGGAmmu-miR-709
1,1616527CGTCCCCGCTCGGCGGGGTCCmmu-miR-689
X10155TGAGGTTGGTGTACTGTGTGTGAmmu-miR-672
1151789AAACCGTTACCATTACTGAGTTmmu-miR-451
X12264TCCCTGAGGAGCCCTTTGAGCCTGmmu-miR-351
mmu-miR-322X11118AAACATGAAGCGCTGCAACACmmu-miR-322*
mmu-miR-424X42177CAGCAGCAATTCATGTTTTGGAmmu-miR-322 
1,414194TGTAAACATCCTACACTCTCAGCmmu-miR-30c
1513392TGTAAACATCCTACACTCAGCTmmu-miR-30b
610684TAGCACCATCTGAAATCGGTTAmmu-miR-29a
9,1021120TTCAAGTAATCCAGGATAGGCTmmu-miR-26a
513309CATTGCACTTGTCTCGGTCTGAmmu-miR-25
1314782ATCACATTGCCAGGGATTACCmmu-miR-23b
811263ATCACATTGCCAGGGATTTCCmmu-miR-23a
1110681TAGCTTATCAGACTGATGTTGAmmu-miR-21
1411415TAAAGTGCTTATAGTGCAGGTAGmmu-miR-20a
1111705TAGCAGCACAGAAATATTGGCmmu-miR-195
mmu-miR-17-5p1412162CAAAGTGCTTACAGTGCAGGTAG(T)mmu-miR-17
3,1431971TAGCAGCACGTAAATATTGGCGmmu-miR-16
318059TAGCAGCACATCATGGTTTACAmmu-miR-15b
mmu-miR-125a1715096TCCCTGAGACCCTTTAACCTGTGAmmu-miR-125a-5p 
1012316TGAGGTAGTAGTTTGTGCTGTTmmu-let-7i
912950TGAGGTAGTAGTTTGTACAGTTmmu-let-7g
mmu-let-7f1320744TGAGGTAGTAGATTGTATAGTTmmu-let-7f-1
1711278TGAGGTAGGAGGTTGTATAGTTmmu-let-7e
1319368AGAGGTAGTAGGTTGCATAGTTmmu-let-7d
mmu-let-7c1622463TGAGGTAGTAGGTTGTATGGTTmmu-let-7c-1
1517747TGAGGTAGTAGGTTGTGTGGTTmmu-let-7b
mmu-let-7a1327015TGAGGTAGTAGGTTGTATAGTTmmu-let-7a-1
Old Sanger 
NomenclatureChromosome
Relative 
FluorescenceMicroRNA Sequence
High 
Abundance
TABLE 2-2: High abundance microRNAs present in periovulatory granulosa 
cells isolated prior to and 4 hours after hCG stimulation. 
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TABLE 2-3: Intermediate abundance microRNAs present in periovulatory 
granulosa cells isolated prior to and 4 hours after hCG stimulation. 
 
 
AKA mmu-miR92b14667TATTGCACTCGTCCCGGCCTChsa-mir-92b
201999AGGCGGGGCGCCGCGGGACCGChsa-mir-663
hsa-mir-57441254CACGCTCATGCACACACCCACAhsa-mir-574-3p
X3458AGAGTAGTAGGTTGCATAGTArno-miR-352
1233CCTTGAGGGGCATGAGGGTrno-miR-327
rno-miR-151*71919TCGAGGAGCTCACAGTCTAGT(A) (OV8)rno-miR-151
111495TGCGGGGCTAGGGCTAACAGCmmu-miR-744
177812CACCCGTAGAACCGACCTTGCGmmu-miR-99b
163216AACCCGTAGATCCGATCTTGTGmmu-miR-99a
X2207TGAGGTAGTAAGTTGTATTGTTmmu-miR-98
55870CAAAGTGCTGTTCGTGCAGGTAGmmu-miR-93
mmu-miR-9214,X7728TATTGCACTTGTCCCGGCCTG      (OV7)mmu-miR-92a
31003ATCTCGCTGGGGCCTCCAmmu-miR-720
66782GGTGGGAGGTGGGGTGGGCAmmu-miR-705
169139AAAGGCTAGGCTCACAACCAAAmmu-miR-690
6,X,121638GGGCATCTGCTGACATGGGGGmmu-miR-680
mmu-miR-67151850AGGAAGCCCTGGAGGGGCTGGAG(G)mmu-miR-671-5p
121358AAGGGATTCTGATGTTGGTCACACTmmu-miR-541
X6146TAGCAGCGGGAACAGTACTGCAGmmu-miR-503
121009TGAAACATACACGGGAAACCTCmmu-miR-494
88230TCCTGTACTGAGCTGCCCCGAGmmu-miR-486
161049TCAGGCTCAGTCCCCTCCCGAT    (OV14)mmu-miR-484
mmu-miR-455-3p41852(AT)GCAGTCCACGGGCATATACAC(T)mmu-miR-455
mmu-miR-450X,X6506(T)TTTTGCGATGTGTTCCTAATATmmu-miR-450a-5p
121595TTTGAACCATCACTCGACTCCTmmu-miR-434-3p
122520TGGTAGACTATGGAACGTAGGmmu-miR-379
X2076TTATCAGAATCTCCAGGGGTACmmu-miR-361
121048TCGGTCGATCGGTCGGTCGGT(CAGT)mmu-miR-341
144514AAAAGCTGGGTTGAGAGGGCGA(A)mmu-miR-320
41336TGTAAACATCCTTGACTGGAAG (OV12)mmu-miR-30e
154303TGTAAACATCCCCGACTGGAAGmmu-miR-30d
mmu-miR-30a-5p14912TGTAAACATCCTCGACTGGAAGmmu-miR-30a
mmu-miR-301111066CAGTGCAATAGTATTGTCAAAGCmmu-miR-301a
mmu-miR-29071044ACTCAAACTATGGGGGCACTTT(TT)mmu-miR-290-5p
135004TTCACAGTGGCTAAGTTCTGCmmu-miR-27b
82688TTCACAGTGGCTAAGTTCCGCmmu-miR-27a
17749TTCAAGTAATTCAGGATAGGT(T)mmu-miR-26b
8,136702TGGCTCAGTTCAGCAGGAACAGmmu-miR-24
114868AAGCTGCCAGTTGAAGAACTGTmmu-miR-22
12037ACAGCAGGCACAGACAGGCAG(T)mmu-miR-214
X3609CAAAGTGCTCATAGTGCAGGTAGmmu-miR-20b
72451AGAGGTATAGCGCATGGGAAGAmmu-miR-202-3p
X9035TGTGCAAATCCATGCAAAACTGAmmu-miR-19b
mmu-miR-199a*1,92253(AT)ACAGTAGTCTGCACATTGGTTAmmu-miR-199a-3p
96507CAACGGAATCCCAAAAGCAGCTGmmu-miR-191
161524TGGAGAGAAAGGCAGTTCCTGAmmu-miR-185
1,23084AACATTCATTGCTGTCGGTGGGTmmu-miR-181b
1,23595AACATTCAACGCTGTCGGTGAGTmmu-miR-181a
144458TAGCAGCACATAATGGTTTGTGmmu-miR-15a
111330TCAGTGCATGACAGAACTTGG(G)mmu-miR-152
182408GTCCAGTTTTCCCAGGAATCCCT(T)mmu-miR-145
181215TGAGATGAAGCACTGTAGCTC(A)mmu-miR-143
81152TACCACAGGGTAGAACCACGG(A)mmu-miR-140*
112333TAACAGTCTACAGCCATGGTCGmmu-miR-132
22475CAGTGCAATGTTAAAAGGGCATmmu-miR-130a
123270TCGGATCCGTCTGAGCTTGGCTmmu-miR-127
21521TCGTACCGTGAGTAATAATGCGmmu-miR-126-3p
mmu-miR-125b177524TCCCTGAGACCCTAACTTGTGAmmu-miR-125b-5p
195834AGCAGCATTGTACAGGGCTATCAmmu-miR-107
55749TAAAGTGCTGACAGTGCAGATmmu-miR-106b
X4237CAAAGTGCTAACAGTGCAGGTAGmmu-miR-106a
2,116225AGCAGCATTGTACAGGGCTATGAmmu-miR-103
91235AACCCGTAGATCCGAACTTGTGmmu-miR-100
131213CTATACGACCTGCTGCCTTTCTmmu-let-7d*
Old Sanger
NomenclatureChromosome
Relative
FluorescenceMicroRNA Sequence 
aIntermediate
Abundance
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 35 
A pairwise t-test cluster analysis of the data from the microarrays found 13 
miRNA transcripts to be differentially expressed between 0 and 4 hours post-
hCG (p-values < 0.05) (Figure 2-1A). Analysis using the National Institute of 
Health Array Analysis tool also found Mirn132 and Mirn212 to be significantly 
upregulated between the 0 and 4 hour time points with fold changes of 16.9 
and 21.7, respectively. Quantitative RT-PCR was used to validate the 
microarray results for these two specific LH-induced miRNAs, as well as one 
other highly upregulated miRNA transcript (Mirn21, data not shown). The fold 
increases seen for the mature forms of both Mirn132 (11.4± 4.2) and Mirn212 
(20.5± 4.0) at 4 hours post-hCG (Figures 2-1B and 2-1C) were similar to the 
expression changes predicted by miRNA microarray analysis. 
 36 
Figure 2-1 
FIGURE 2-1: Microarray cluster analysis for mural granulosa cells collected 
46 hours after in vivo eCG (0 hour control) or after eCG + 4 hours post-hCG 
treatment of mice. Paired t-test analyses of the microarray data (n=3) 
revealed: (A) 13 miRNA transcripts to be statistically different (P<0.05) 
between 0 and 4 hours post-hCG; (B, C) qRT-PCR analyses for the highly 
 37 
Temporal Expression of miRNAs in Granulosa Cells In Vivo 
In vivo expression patterns for mature Mirn132 and Mirn212 were 
determined by qRT-PCR within mural granulosa cells. Examination of miRNA 
levels over the 12 hour periovulatory period demonstrated that Mirn132 and 
Mirn212 expression remained unchanged 1 hour following hCG 
administration, then were significantly upregulated between 2 hours and 12 
hours post-hCG to 17- and 34-fold over the basal levels (0 hour control) for 
Mirn132 and Mirn212, respectively (Figure 2-2A and 2-2B). 
Quantitative RT-PCR analysis of the pri-miRNA transcript in 
periovulatory granulosa cells collected after in vivo hCG treatment indicated 
that both the Mirn132 and Mirn212 originate from a single transcript and that 
increased expression occurred approximately 1 hour prior to the detection of 
the mature forms (Figure 2-2C). Changes in pri-miRNA expression preceded 
those changes that were observed in the mature forms (when comparing 2-
2C to 2-2A and 2-2B). 
 38 
0
10
20
30
0 1 2 4 6 8 12
Hours Post-hCG
M
irn
13
2/
21
2_
pr
i F
o
ld
 
Ch
a
n
ge
(no
rm
a
liz
e
d 
to
 
GA
PD
H
)
b b 
a,b
a,b a,b
a
a
M
irn
13
2/
21
2_
pr
i F
o
ld
 
Ch
a
n
ge
(no
rm
a
liz
e
d 
to
 
GA
PD
H
)
0
10
20
30
40
50
0 1 2 4 6 8 12
Hours Post-hCG
M
irn
21
2
 
Fo
ld
 
Ch
a
n
ge
(no
rm
a
liz
e
d 
to
 
GA
PD
H
)
b                            b
b              b    b
a             aM
irn
21
2
 
Fo
ld
 
Ch
a
n
ge
(no
rm
a
liz
e
d 
to
 
GA
PD
H
)
0
10
20
30
0 1 2 4 6 8 12
Hours Post-hCG
M
irn
13
2
 
Fo
ld
 
Ch
a
n
ge
(no
rm
a
liz
e
d 
to
 
GA
PD
H
)
b                b      
b
b b
a            aM
irn
13
2
 
Fo
ld
 
Ch
a
n
ge
(no
rm
a
liz
e
d 
to
 
GA
PD
H
)
A
B
C
Figure 2-2 
FIGURE 2-2: qRT-PCR 
analysis of mature 
Mirn132 (A), mature 
Mirn212 (B) and the 
Mirn132/212_pri 
transcript levels in 
mural granulosa cells 
collected from mice 
following in vivo 
treatment of eCG for 46 
hours (i.e., 0 hour) and 
eCG + hCG for 1 to 12 
hours post-hCG. 
Mature Mirn132 and 
Mirn212 levels were 
normalized to GAPDH.   
a,b
 Means ± SEM with 
different superscripts 
are different (P<0.05). 
 39 
Quantitative RT-PCR analysis for the factors involved in the synthesis of 
miRNAs indicated the presence of the essential miRNA processing 
components (i.e., Rnasen (Drosha), Xpo5, DGCR8 and Dicer1) within the 
purified population of granulosa cells and showed that an ovulatory surge of 
LH/hCG had no effect on the expression of these factors in vivo (see Figure 
2-3).  
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Temporal Expression of miRNAs in Granulosa Cells in Vitro 
 To determine whether LH/hCG-induced miRNAs were downstream of 
the cAMP signal transduction pathway, isolated granulosa cells from 
preovulatory follicles (27d old mice) were placed in culture. Plates were 
typically ~20% confluent one day following plating. Cells continued 
proliferating in culture so that by the second day the cells were near 50% 
confluent. On the third day of culture, cells were exposed to 8-Br-cAMP 
treatment for 0 to 12 hours, mimicking the predominant second messenger 
system downstream of LH/hCG used in our in vivo experiments. The in vitro 
granulosa cell expression patterns for Mirn132 and Mirn212 were similar to 
that observed in vivo. However, the increases seen in vitro were more rapid 
as Mirn132 and Mirn212 were increased within 1 hour of 8-Br-cAMP 
treatment. Mature Mirn132 and Mirn212 levels remained elevated for the 
entire 12 hour cAMP treatment reaching their peak levels (10- and 16-fold 
increases respectively) at 8 hours post treatment (Figures 2-4A and 2-4B). 
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Figure 2-4 
FIGURE 2-4: qRT-PCR analysis of mature Mirn132 (A) and Mirn212 (B) 
expression in cultured granulosa cells following treatment with 8-Br-cAMP.  
Mature Mirn132 and Mirn212 levels were normalized to GAPDH.   a,b,c 
Means ± SEM with different superscripts are different (P<0.05). 
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Analysis of miRNA Expression Following In Vitro miRNA Knockdown with 
LNA Oligonucleotides     
To gain insight as to what Mirn132 and Mirn212 are regulating in 
granulosa cells and to begin to dissect the functional role these miRNAs have 
on granulosa cell function, we chose to knockdown expression of these 
factors using LNA oligonucleotides complementary to the miRNAs. 
Transfection combining LNA oligonucleotides for both Mirn132 and Mirn212 
were effective in knocking down their respective target miRNAs (Figure 2-5). 
The cAMP stimulated levels of mature Mirn132 (panel A) and Mirn212 (panel 
B) were completely blocked by the LNA treatment. Conversely, treatment with 
the LNA oligos specific to Mirn132 and Mirn212 had no effect on the 
expression of Mirn21 (Figure 2-5C), a miRNA that is unresponsive to cAMP 
stimulation in vitro but is upregulated within granulosa cells following the LH 
surge (data not shown).  
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Figure 2-5 
FIGURE 2-5:  qRT-PCR 
analysis of mature 
Mirn132, Mirn212 and 
Mirn21 expression in 
cultured granulosa cells 
following transfection with 
LNAs to Mirn132 and 
Mirn212 and subsequent 
treatment with 8-Br-cAMP 
(n=3). Granulosa cells 
were transfected with 
Mirn132-LNA and 
Mirn212-LNA (20nM of 
each) as well as a non-
specific scramble LNA 
(40 nM) for 24 hours prior 
to treatment with 8-Br-
cAMP. Cells were then 
collected 24 hours 
following 8-Br-cAMP 
treatment. Mature levels 
of Mirn132 (A), Mirn212 
(B) and Mirn21 (as known 
as miR-21) (C) were 
normalized to GAPDH. a,b 
Means ± SEM with 
different superscripts are 
different (P<0.05). 
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Following knockdown with a combination of 132 and 212 LNA 
oligonucleotides, we evaluated whether there was any effect on 
steroidogenesis. Medium concentrations of estrogen and progesterone were 
measured at the completion of the each experiment and knockdown of the 
miRNAs failed to affect medium estradiol or progesterone at 12 and 24 hours 
after cAMP treatment. Treatment of granulosa cells with cAMP increased 
progesterone synthesis ~ 6-fold as expected (steroid data not shown).    
 
Identification of Mirn132 and Mirn212 Targets 
 To gain insight into the possible target mRNAs that these miRNAs may 
regulate, a comprehensive list of Mirn132 and Mirn212 target genes was 
created through the use of the PicTar algorithm [106]. This analysis yielded 
156 or 157 mRNA transcripts as predicted targets of murine Mirn132 and 
Mirn212, respectively. A comparison of these transcripts to genes expressed 
in granulosa cells at either 0 and 1 hour post-hCG or 8 hours post-hCG 
revealed 77 common transcripts (see Table 2-5). These transcripts were then 
evaluated using several other miRNA target prediction algorithms, and those 
results are also shown in Table 2-5. Ingenuity pathway analysis indicated that 
a large number of these transcripts were in the cellular development and 
gene expression ontology groups. 
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TABLE 2-5: Ovarian granulosa cell mRNA transcripts that contain putative 
Mirn132 recognition sites. 
1A, BNM_011768Zfx, zinc finger protein X-linked
1, 2aANM_001012330Zfp238, zinc finger protein 238
1ANM_015753Zfhx1b, zinc finger homeobox 1b
ANM_001039180Zeb2, zinc finger E-box binding homeobox 2
A, BNM_153555Wdr42a, WD repeat domain 42A
A, BNM_011695Vdac2, voltage-dependent anion channel 2
A, BNM_013933Vapa, vesicle-associated membrane protein, associated protein A
A, BNM_009481Usp9x, ubiquitin specific peptidase 9, X chromosome
1aA, BNM_025356Ube2d3, ubiquitin-conjugating enzyme E2D 3 (UBC4/5 homolog, yeast) mRNA
1ANM_010286Tsc22d3, TSC22 domain family 3
1ANM_030706Trim2, tripartite motif protein 2
1aANM_144551Trib2, tribbles homolog 2 (Drosophila)
1aA, BNM_029478Tmem49, transmembrane protein 49
1, 2aBNM_021436Tmeff1, transmembrane protein with EGF-like and two follistatin-like domains 1
1A, BNM_027016Tloc1, translocation protein 1
1, 2BNM_013896TIM9A_MOUSE, Mitochondrial import inner membrane translocase subunit TIM9 A.
1aANM_009333Tcf7l2, transcription factor 7-like 2, T-cell specific, HMG-box
1, 2A, BNM_009332Tcf3, transcription factor 3
1ANM_011444Sox5, SRY-box containing gene 5
1aANM_130796Snag1, sorting nexin associated golgi protein 1
A, BNM_053124Smarca5, SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 5
1ANM_144798Slc30a6, solute carrier family 30 (zinc transporter), member 6
1ANM_019812Sirt1, sirtuin 1 ((silent mating type information regulation 2, homolog) 1 (S. cerevisiae)
A, BNM_173374Sfrs1, splicing factor, arginine/serine-rich 1 (ASF/SF2)
1ANM_011976
Sema4g, sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic 
domain, (semaphorin) 4G
A, BNM_194051Rtn4, reticulon 4
A, BNM_021881Qk, quaking
1A, BNM_008960Pten, phosphatase and tensin homolog
1a, 2aANM_008858Prkcm, protein kinase C, mu
1, 2A, BNM_008014Ppm1g, protein phosphatase 1G (formerly 2C), magnesium-dependent, gamma isoform
1A, BNM_148932Pom121, nuclear pore membrane protein 121
1, 2A, BNM_008891Pnn, pinin
1ANM_018807Plagl2, pleiomorphic adenoma gene-like 2
1, 2bA, BNM_019410Pfn2, profilin 2
1bANM_013875Pde7b, phosphodiesterase 7B
1, 2A, BNM_026420Paip2, polyadenylate-binding protein-interacting protein 2
A, BNM_176840Osbpl11, oxysterol binding protein-like 11
1ANM_019498Olfm1, olfactomedin 1
A, BNM_008702Nlk, nemo like kinase
1A, BNM_010913Nfya, nuclear transcription factor-Y alpha
A, BNM_177619MYST histone acetyltransferase 2
1A, BNM_010788Mecp2, methyl CpG binding protein 2
A, BNM_011949Mapk1, mitogen activated protein kinase 1
1ANM_009582Map3k12, mitogen activated protein kinase kinase kinase 12
A, BNM_029789Lass2, longevity assurance homolog 2 (S. cerevisiae)
ANM_133721Itga9, integrin alpha 9
1, 2A, BNM_029804Hnrpm, heterogeneous nuclear ribonucleoprotein M
A, BNM_021510Hnrph1, heterogeneous nuclear ribonucleoprotein H1
1, 2A, BNM_008258Hn1, hematological and neurological expressed sequence 1
1, 2ANM_010415Hbegf, heparin-binding EGF-like growth factor
1A, BNM_008211H3f3a, H3 histone, family 3B
1A, BNM_016750H2afz, H2A histone family, member Z
ANM_019827Gsk3b, glycogen synthase kinase 3 beta
1A, BNM_016739Gpiap1, GPI-anchored membrane protein 1
1A, BNM_057172Fubp1, far upstream element (FUSE) binding protein 1
2A, BNM_008020Fkbp2, FK506 binding protein 2
1, 2A, BNM_013506Eif4a2, eukaryotic translation initiation factor 4A2
BNM_010104Edn1, endothelin 1
1ANM_153743Dnmt3a, DNA methyltransferase 3A
1A, BNM_145959D15Ertd621e, MKIAA0493 protein (Fragment).
1A, BNM_144901CSDE1_MOUSE, Cold shock domain protein E1.
1A, BNM_009919Cnih, cornichon homolog (Drosophila)
1A, BNM_007688Cfl2, cofilin 2, muscle
1, 2bA, BNM_007594Calu, calumenin
1A, BNM_009764Brca1, breast cancer 1
1, 2A, BNM_016787Bnip2, BCL2/adenovirus E1B 19kDa-interacting protein 1, NIP2
ANM_029791Bicd2, bicaudal D homolog 2 (Drosophila)
A, BNM_153125AU024582, expressed sequence AU024582
1A, BNM_009715Atf2, activating transcription factor 2
A, BNM_175251Arid2, AT rich interactive domain 2 (Arid-rfx like)
1A, BNM_178803Aebp2, AE binding protein 2
1, 2A, BNM_0265566720463E02Rik, Dynein light chain 2, cytoplasmic (8 kDa dynein light chain) (DLC8) (DLC8b).
1A, BNM_0234236330407G11Rik, RIKEN cDNA 6330407G11 gene (6330407G11Rik), mRNA
ANM_0242825830417C01Rik, UPF0326 protein CGI-146 homolog.
1, 2A, BNM_0256905730555F13Rik, modulator of estrogen induced transcription isoform a
ANM_1724684732481H14Rik, RIKEN cDNA 4732481H14 gene (4732481H14Rik), mRNA
1A, BNM_1768362810485I05Rik, RIKEN cDNA 2810485I05 gene (2810485I05Rik), mRNA
miRanda and 
miRBase
Algorithm 
Comparison#
Microarray*Ref SeqDNA IDGENE NAME
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 Additionally, three recently identified Mirn132 target transcripts were 
examined to determine if they were differentially expressed in murine 
granulosa cells. Quantitative RT-PCR indicated that LH increased expression 
of Grit (the mouse homolog to p250 GAP) at 6 and 12 h post-hCG (Figure 2-
6A). Conversely, MeCP2 and CtBP1 were not transcriptionally regulated 
(Figure 2-6B and  2-6C). Western blot analysis for CTBP1 protein in 
granulosa cells following in vitro LNA treatment indicated that loss of miRNA 
function caused a marked decline in the translation of this target protein 
(Figure 2-6D). 
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DISCUSSION 
 This study is the first to describe the hormonal regulation of miRNA 
expression in the ovary, specifically the ability of the LH/hCG surge to 
mediate changes in the expression of miRNAs within periovulatory granulosa 
cells. The ovarian granulosa cell is likely a prime target for miRNA mediated 
changes in gene expression due to the rapid conversion this cell must 
undergo following the LH surge. This phenotypic change requires the global 
loss of its follicular phenotype and its attendant gene expression/protein 
profile as well as the rapid induction of a luteal phenotype. We chose to 
examine the expression and function of the two miRNAs (Mirn132 and 
Mirn212) that exhibited the greatest difference in expression following the 
hCG/LH surge. The recent functional description of Mirn132 in neuronal cells, 
combined with the fact that both Mirn132 and Mirn212 are regulated by the 
cAMP regulatory element binding protein (CREB), also made these miRNAs 
attractive to study [61]. 
 From the microarray data, we identified 212 independent, mature 
miRNA transcripts in periovulatory mural granulosa cells that were above 
background levels in at least 2 of 3 samples for the 0 and 4 hour time points. 
These results are in striking contrast to the list of 122 miRNAs cloned from 
whole ovarian tissues recently by Ro et al. [108]. Of interest, approximately 
20% of these transcripts are variants at the 5’ and 3’ ends, and as noted by 
the authors, a consequence that may be due to the cloning procedure. 
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Alternatively, editing of the miRNA ends, which was recently described, may 
also be involved [109]. A more conservative interpretation indicates that they 
identified 97 miRNAs combined from two week-old and adult mouse ovaries. 
Comparison of our list to the Ro et al. [108] list of 97 bonafide miRNAs cloned 
from whole ovaries indicates that ~80% of the transcripts overlap. Moreover, 
the relative abundance of each miRNA transcript (i.e., fluorescent value) 
observed in our experiments was predictive of the cloning method’s ability to 
detect the transcript in the whole ovary. For example, 24 of 31 miRNA 
transcripts in our high fluorescence group, 28 of 64 miRNA transcripts in our 
intermediate, and 25 of 117 miRNA transcripts in the low group were detected 
by Ro et al. (2007) [108]. Those transcripts found in both lists are bolded in 
Tables 2-2, 2-3, and 2-4. Interestingly, several miRNAs including Mirn132 and 
Mirn212, the two differentially expressed miRNAs with intermediate to low 
fluorescent levels we detected, were not detected in their analysis at all. 
Because our preparations of granulosa cells are not contaminated with 
oocytes as they were eliminated by size exclusion filtering, we can be 
confident that our results reflect the changes seen in the somatic cell 
compartments and are not the result of an effect of the germ cells/oocytes. 
Therefore, we believe that the miRNA microarray approach we used has 
provided us with a robust analysis of miRNA expression within the 
periovulatory granulosa cell. We recognize that novel granulosa cell miRNAs 
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may have been missed in our approach; however, presently this approach 
yields a much higher number of miRNAs as compared to a cloning method.     
 The miRNAs that fail to experience a differential expression pattern 
within granulosa cells after the LH surge have the potential to be very 
interesting as they may also play a role in ovarian function. Indeed, it has 
recently been demonstrated that miRNAs can both block and/or enhance 
translation dependent upon the cell cycle state [97]. MiRNAs regulate 
translation by recruiting the RNA induced silencing complex to the 3’UTR of 
mRNAs where they can prohibit further translation [96]. Recently, Vasudevan 
et al. [30] demonstrated that miRNAs could enhance translation under 
conditions that promote cellular differentiation by recruiting Argonaute 2 to 
this complex. Under this paradigm, highly expressed miRNAs in particular, 
while not exhibiting hormonally dependent regulation in expression, may still 
exhibit a dynamic regulatory role in response to a hormone-dependent shift of 
a key regulatory factor (i.e., an argonaute protein). This type of cellular event 
occurs in periovulatory granulosa cells as they transition from highly 
proliferative follicular cells to terminally differentiated luteal cells and could 
indicate that these highly abundant ovarian granulosa cell miRNAs, which are 
present prior to the LH surge, may be preventing the translation of genes 
critical for luteinization and ovulation. It is possible that these miRNAs only 
release their block on mRNA translation following the LH surge; alternatively 
these miRNAs may be necessary for the efficient translation of specific 
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mRNAs in the ovary after the LH surge. Subsequent studies will be necessary 
to determine the importance specific miRNAs have on ovarian granulosa cell 
function. 
 The qRT-PCR results for Mirn132 and Mirn212 indicated that in vivo 
these transcripts are rapidly upregulated by the LH surge and that their 
mature forms remain elevated even after transcriptional decline of the 
precursor form. This suggests a fairly long half-life for the mature forms. Our 
in vitro experiments demonstrate that the robust induction of Mirn132 and 
Mirn212 seen in response to in vivo LH/hCG treatment is likely due to the 
cAMP cell-signaling cascade. This coincides with the recent observation that 
cAMP was able to mediate an increase in Mirn132 levels within rat 
pheochromocytoma cells (PC12 cells) [61, 74]. Vo et al. [61] also 
demonstrated several CREB response elements located immediately 
upstream of each pre-miRNA sequence to be critical for Mirn132 expression. 
Our analysis of the pri-miRNA transcript and that of the exonic regions of 
AK006051, the gene that contains the pri-miRNA transcript for Mirn132 and 
Mirn212 within its first intron, suggests the gene promoter that guides the 
expression of the mRNA transcript for AK006051 likely plays a significant role 
in the biogenesis of these miRNAs (data not shown). Vo et al. demonstrated 
by 5’ cap trapping RACE and 3’ RACE that the pri-miRNA transcript did not 
contain a significant open reading frame [61]. Transcriptional regulation of 
miRNAs is just now beginning to be unraveled, and the transcription of pri-
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miRNAs appears to be just as complex as the transcription of protein-
encoding genes [42, 45]. This work is a beginning point for future studies 
concerning the regulation of expression of these two particular miRNAs within 
ovarian granulosa cells.      
To facilitate the identification of proteins and to determine the 
physiologic role that these LH-regulated miRNAs might be having on 
granulosa cell function, we used both a computational approach and a 
knockdown approach. The results of our computational analyses indicate that 
a large number of 3’UTRs contain Mirn132/212 seed sequences. Comparison 
of these lists to the total number of genes present in ovarian granulosa cells 
after follicular stimulation (i.e., 46 hours of eCG and 1 h post-hCG and 8 h 
after hCG treatment) yielded a list of 77 transcripts with putative Mirn132/212 
recognition sites. Most of these genes are not specific to ovarian function, and 
their role in ovarian cell function is unknown. However, several transcripts 
have been confirmed as Mirn132/212 targets in other tissues. The MECP2, 
CTBP1 and p250 GTPase activating-protein (GAP; also known as GRIT 
within the murine genome) proteins have been shown to regulate neuronal 
dendritic branching [61, 74]. Interestingly, CTBP1 was recently shown to 
interact with steroidogenic factor-1 [78] in adrenal cells to modulate its ability 
to stimulate promoter activity. Our studies indicate that CTBP1 is post-
transcriptionally regulated as evidenced by the lack of change in its mRNA 
levels in response to in vivo hCG treatment combined with the pronounced 
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loss in the protein when miRNA-function blocking LNA oligonucleotides were 
administered. CTBP1 acts as a co-repressor of nuclear receptor target genes 
[78]. Therefore, our data suggest that CtBP1 translation is upregulated in 
response to LH/hCG/cAMP induction of Mirn132 and Mirn212.  In turn, this 
co-repressor could play key regulatory roles in mediating changes in global 
gene transcription. We were unable to confirm whether p250GAP (GRIT) and 
MECP2 were post-transcriptionally regulated due to the lack of suitable 
antibodies.  
 In summary, these studies are the first to elucidate the extent of 
miRNA expression within ovarian granulosa cells and to identify hormonally-
regulated miRNAs within periovulatory granulosa cells. The two highly LH-
induced miRNAs, Mirn132 and Mirn212, share the same seed sequence and 
were shown to be transcribed as a single pri-miRNA. The loss of induction of 
CTBP1 protein synthesis following ablation of functional Mirn132 and Mirn212 
suggests that these miRNAs may play a key role through indirect regulation of 
gene transcription in ovarian granulosa cell. Further studies are necessary to 
identify how these miRNAs mediate changes in expression of CTBP1 as well 
as to identify the genes downstream of this co-repressor. 
 55 
Chapter 3 
Quantitative RT-PCR Methods for Mature MicroRNA 
Expression Analysis 
 
SUMMARY 
This paper describes two methods to measure expression of mature 
miRNA levels using qRT-PCR. The first method uses stem-loop RT primers to 
produce cDNA for specific miRNAs, a technique that our laboratory has 
modified to increase the number of miRNAs being reverse transcribed within 
a single RT reaction from one (as suggested by the manufacturer) to five. The 
second method uses a modified oligo(dT) technique to reverse transcribe all 
transcripts within an RNA sample; therefore, target miRNA and normalizing 
mRNA can be analyzed from the same RT reaction. We examined the level of 
miRNA-132, a miRNA known to be upregulated in granulosa cells following 
hCG treatment, using both of these methods. Data was normalized to 
GAPDH or snU6, and evaluated by ∆∆Ct and standard curve analysis. There 
was no significant difference (P>0.05) in miRNA-132 expression between the 
stem-loop and modified oligo(dT) RT methods indicating that both are 
statistically equivalent. However, from a technical point of view, the modified 
oligo(dT) method was less time consuming and only required a single RT 
reaction to reverse transcribe both miRNA and mRNA. 
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1. INTRODUCTION 
MicroRNA (miRNA) are endogenous, non-coding single-stranded RNA 
molecules that are ~22 nucleotides in length [27]. Discovered less than 20 
years ago, 695 miRNA have now been identified in the human genome 
(miRBase Database Version 12.0) and estimates indicate that >1000 exist 
[46, 101, 102]. MicroRNA have been associated with many biological 
processes including tissue development, proliferation and differentiation [27, 
98, 110], and research links specific miRNA to heart disease and many types 
of cancer [111-114]. The sequential processing of a primary miRNA transcript 
(pri-miRNA) to yield a precursor miRNA (pre-miRNA) and ultimately a mature, 
single stranded miRNA that associates with the RNA-induced silencing 
complex is well described [27, 33, 40]. MicroRNA microarrays and Northern 
blotting both provide reliable detection of mature miRNA, but are time 
consuming, require more starting material, and do not provide the accuracy or 
precision offered with quantitative RT-PCR (qRT-PCR; [115]). 
Analysis of mature miRNA by PCR presents a unique problem as the final 
length of a miRNA transcript is similar to the primers needed to amplify them. 
Therefore, expression analysis of mature miRNA has required the 
development of specialized primers for reverse transcription (RT) or extension 
of the transcript prior to qRT-PCR. Use of a stem-loop reverse transcriptase 
primer (described in Figure 3-1 and Subheading 3.2.1; [116]) or a long 
primer (used in the miR-Q method; [117]) specific to each miRNA is used to 
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convert total RNA into cDNA. Amplification is then achieved using a primer 
set containing a primer specific to the mature miRNA of interest and a primer 
specific to a region of the stem-loop sequence or miR-Q primer [116, 117]. 
Another approach is to add polyA tails to all transcripts within a sample then 
reverse transcribe using a set of 12 modified oligo(dT) primers containing a 
unique sequence tag at the 5` end and two bases at the 3` end (as described 
in Figure 3-1 and Subheading 3.2.3; [118]). Amplification is then achieved 
using a PCR primer specific to the miRNA of interest and a primer specific to 
the tag. Unlike the stem-loop primer RT reaction and the miR-Q method, this 
RT reaction converts all miRNA and mRNA into cDNA within a single 
reaction. In this chapter, we discuss modifications that we have made to the 
stem-loop primer system that allow for simultaneous measurement of up to 5 
miRNA. We also compare the stem-loop and polyA tail/modified oligo(dT) RT 
systems for miRNA-132 expression within murine granulosa using either a 
standard curve or ∆∆Ct method of quantification. 
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Figure 3-1 
FIGURE 4-1: Graphical representation of RT and PCR methods used to 
analyze the expression of mature miRNAs. 
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2. MATERIALS 
2.1 RNA Extraction 
2.1.1 Materials 
1. 19 day old CF-1 mice (20-25g) 
2. Disposable latex gloves 
3. Pipets (P2, P20, P100, P1000) 
4. Sterile, RNase/DNase free filter pipet tips (to dispense volumes 
between 0.2 -1000 ul) 
5. Benchtop centrifuge (refrigerated if possible) 
6. Sterile, RNase/DNase free 1.5 ml microcentrifuge tubes 
7. -70°C freezer 
8. NanoDrop-1000 Spectrophotometer (NanoDrop Technologies, 
Wilmington, DE) 
 
2.1.2 Solutions and Reagents 
1. TRIZOL (Invitrogen, #15596-018) 
2. Chloroform (Sigma, #C2432-500ML) 
3. Glycogen (Invitrogen, #10814-010) 
4. Isopropanol 
5. 75% Ethanol 
6. Ice 
7. DEPC water 
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2.2 Reverse Transcription 
2.2.1 RT Materials 
1. Vortexer 
2. Benchtop microcentrifuge 
3. Thermocycler 
4. 0.5 ml sterile PCR tubes with caps 
5. Heating block or water bath (capable of reaching 95°C) 
 
2.2.2 Stem-Loop Primer Reagents 
1. TaqMan MicroRNA Reverse Transcription Kit (Applied Biosystems, 
#4366597) 
2. hsa-miR-132 Human MicroRNA Assay Kit (Applied Biosystems, 
#4373143) (see Note 1) 
3. hsa-miR-212 Human MicroRNA Assay Kit (Applied Biosystems, 
#4373087) 
4. hsa-miR-30b Human MicroRNA Assay Kit (Applied Biosystems, 
#4373290) 
5. dNTPs (Invitrogen, #18427013) 
6. Random Primers (Invitrogen, #48190011) 
7. MMLV reverse transcriptase (with DTT and 5X RT Buffer; Invitrogen, 
#28025013) 
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2.2.3 Modified Oligo(dT) Primer Reagents 
1. miScript Reverse Transcriptase Kit (Qiagen, #218061) 
 
2.3 Quantitative RT-PCR  
2.3.1 qRT-PCR Materials 
1. Applied Biosystems 7900HT Sequence Detection System (may be 
substituted with other real-time machines) 
2. Rainin 250 ul EDP-Plus electronic repeat pipetter 
3. ABI Prism 384-well optical reaction plate (Applied Biosystems, 
#4309849) 
4. ABI Prism optical adhesive covers (Applied Biosystems, #4311971) 
5. Optical cover applicator tool 
6. Centrifuge with swinging bucket optical plate holders 
 
2.3.2 Stem-Loop Primer PCR Reagents 
1. hsa-miR-132 Human MicroRNA Assay Kit (also used in RT reaction, 
see Note 1) 
2. TaqMan Rodent GAPDH Control Reagents (Applied Biosystems, cat. 
#4308313) 
3. TaqMan 2X Universal PCR Master Mix, No AmpErase UNG (Applied 
Biosystems, cat. #4324018) 
4. Small nuclear RNA U6 (snU6) primer set - f: ctcgcttcggcagcaca;  
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 r: aacgcttcacgaatttgcgt (Integrated DNA Technologies) [119] 
5. SYBR Green (Invitrogen, cat. #4309155) 
 
2.3.3 Modified Oligo(dT) Primer RT Reagents 
1. miScript SYBR Green PCR Kit (Qiagen, cat. #218073) 
2. Mm_miR-132_1 miScript Primer Assay (Qiagen, cat. #MS00001561) 
(see Note 2) 
3. TE Buffer, pH 8.0 
4. TaqMan Rodent GAPDH Control Reagents (Applied Biosystems, cat. 
#4308313) 
5. Small nuclear RNA U6 (snU6) primer set - f: ctcgcttcggcagcaca; r: 
aacgcttcacgaatttgcgt (Integrated DNA Technologies, Coralville, IA) 
[119] 
 
2.4 Data Analysis 
1. Microsoft Office 2003 
2. GraphPad Prism (version 4.0) 
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3. METHODS 
3.1 RNA Extraction and Dilution 
1. Granulosa cells from CF-1 mice (n=3 for each time point) were 
collected prior to hCG (0h) or 4h and 6h after hCG treatment as 
previously described in detail [120]. 
2. Total RNA was isolated from granulosa cells using TRIZOL (1 ml per 
sample; Invitrogen) with a few modifications to the manufacturer’s 
protocol as described below (see Note 3): 
a. Chloroform (200 ul) was added to each tube and tubes were 
vigorously shaken by hand for 15 seconds before being allowed to 
rest at room temperature for 5-10 minutes. 
b. Tubes were centrifuged at 16,100 g for 10 minutes at 4°C. 
c. Aqueous phase (top layer) was carefully removed from each tube, 
transferred into a new tube, and then 2 ul glycogen (20 µg/µl stock) 
was added to each tube (see Note 4). Samples were gently mixed, 
then 500 ul isopropanol was added to each tube.  
d. Samples were vortexed, incubated at room temperature for 10 
minutes, and then centrifuged at 16,100 g for 10 minutes at 4°C. 
e. Supernatant was poured off (being careful not to lose the pellet), 
and then the sample was washed with 75% ethanol. 
f. Tubes were centrifuged at 16,100 g for 10 minutes at 4°C, and the 
supernatant was then poured off. 
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g. The RNA pellet was air dried until edges of the pellet began to look 
clear, then the pellet was rehydrated with 20 ul DEPC water. 
Samples were gently pipetted several times to completely dissolve 
the pellet then immediately placed on ice until RNA quality and 
concentration determinations were completed. 
3. Absorbance and concentration (ng/ul) for each RNA sample was 
determined with a NanoDrop-1000 spectrophotometer.  The ratio of the 
absorbance at 260 and 280 was used to determine the purity of each 
sample. Values ≥1.8 were considered acceptable (see Note 5). 
4. Aliquots of all 9 RNA samples were diluted with DEPC water to yield 
30-50 ul volumes of 50 ng/ul solutions of total RNA. These dilutions 
were then used in all subsequent RT reactions. Stock and diluted RNA 
was stored at -70°C until RT reactions were performed.  
 
3.2 RT Reactions 
3.2.1 Stem-Loop Primer RT for Analysis of Multiple (3-5) MicroRNAs 
1. Total RNA (250 ng) of the dilution prepared in Subheading 3.1.4 was 
reverse transcribed with a combination of three miRNA primers 
(miRNA-132, miRNA-212, and miRNA-30b; Applied Biosystems; see 
Note 6; [120]). Simultaneous RT reactions for 4 or 5 miRNA are 
explained in Note 7. 
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2. The master mix for a 3 miRNA RT reaction contained 0.15 ul dNTP 
mix, 1.0 ul Multiscribe RT enzyme, 1.5 ul 10X RT buffer, 0.19 ul RNase 
Inhibitor, 1.16 ul nuclease-free water, and 6 ul of RT primers (2 ul of 
each miRNA-132, miRNA-212 and miRNA-30b RT primers). All 
reagent volumes are listed as per reaction. The final master mix 
volume was increased by 10% to prevent a shortage of master mix 
solution.  
3. Master mix (10 ul) and total RNA (5 ul of 50 ng/ul; 250 ng) were 
pipetted into PCR tubes which were loaded into an thermocycler using 
the following settings: 16°C for 30 minutes, 42°C for 30 minutes, 85°C 
for 5 minutes, hold at 4°C.  
4. After reverse transcription, samples were diluted 1:15 with DEPC 
water. Stocks and dilutions were stored at -20°C. 
 
3.2.2 Random Primer RT for Normalization of Stem-Loop qRT-PCR 
1. Total RNA (1 ug of the 50 ng/ul dilutions made in Subheading 3.1.4) 
was reverse transcribed for GAPDH and snU6 normalization using 
random primers (Invitrogen; see Note 8). 
2. The random primer master mix contained 2 ul dNTPs, 0.5 ul random 
primers (100 ng/ul), and 5.5 ul DEPC water (all reagent volumes are 
listed as per reaction). The final volume of the master mix was 
calculated as the sum of the total number of reactions plus 10%. 
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3. Random primer master mix (8 ul) and total RNA (20 ul of 50 ng/ul) 
were placed in 1.5 ml microcentrifuge tubes which were then vortexed, 
briefly spun down, and placed in a 65°C water bath for 5 minutes. 
4. Tubes were chilled on ice for 5 minutes immediately after removal from 
the water bath. 
5. A second master mix was prepared containing 2 ul DTT (0.1 M) and 8 
ul 5X RT Buffer (volumes are calculated per reaction). Master mix (10 
ul) and 2 ul MMLV reverse transcriptase (Invitrogen) were added to 
each tube (see Note 9). Each sample was vortexed and centrifuged 
briefly then placed in a 37°C water bath for 2 hours. 
6. The enzymatic reaction was inactivated by placing tubes in a 72°C 
water bath for 15 minutes. Reverse transcribed samples were diluted 
1:10 with DEPC water. Stocks and 1:10 dilutions were stored at -20°C. 
 
3.2.3 Modified Oligo(dT) RT 
1. Total RNA (250 ng) from the sample dilutions prepared in Subheading 
3.1.4 was reverse transcribed with the miScript Reverse Transcription 
Kit (Qiagen; see Note 10). All RT reactions were performed according 
to the manufacturer’s instructions.  
2. The master mix contained 4 ul miScript RT Buffer (5X), 1 ul miScript 
reverse transcriptase mix, and 10 ul DEPC water (all reagent volumes 
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are listed as per reaction). The final volume of the master mix was 
calculated as the sum of the total number of reactions plus 10%. 
3. Master mix (15 ul) and total RNA (5 ul of 50 ng/ul) were placed in 1.5 
ml microcentrifuge tubes which were then vortexed, briefly spun down, 
and placed in a 37°C water bath for one hour. 
4. The enzyme reaction was inactivated by incubating all samples on a 
95°C heating block for 5 minutes. Reverse transcribed samples were 
diluted 1:5 with DEPC water. Stocks & dilutions were stored at -20°C. 
 
3.3 Quantitative Real Time PCR Reactions 
3.3.1 Generation of Standards for qRT-PCR Assays (see Note 11) 
1. Stock cDNA from the stem-loop RT reactions (Subheading 3.2.1, 
step 4) was used to generate a standard curve for miRNA-132 qRT-
PCR reactions (see Note 12). 
2. Stock cDNA from the random primer RT reactions (Subheading 
3.2.2, step 6) was used to generate a standard curve for GAPDH and 
snU6 qRT-PCR reactions (see Note 12). 
3. Stock cDNA from the modified oligo(dT) RT reactions (Subheading 
3.2.3, step 4) was used to generate a standard curve for miRNA-132, 
GAPDH, and snU6 qRT-PCR reactions (see Note 12). 
4. Standard curves were generated by serial dilution of above stock 
cDNAs as outlined in Table 3-1 (see Notes 11 and 12).
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 3.3.2 qRT-PCR Using the Stem-Loop RT Product 
1. For amplification and detection of mature miRNA-132, qRT-PCR was 
run in triplicate (10 ul reaction volumes) for standards, samples and 
negative controls (see Note 13) using the miRNA-132 specific primers 
and probe provided in the hsa-miRNA-132 Human MicroRNA Assay 
Kit (Applied Biosystems). 
2. A master mix consisted of 0.35 ul hsa-miR-132 primer set, 5 ul 
TaqMan 2X Universal PCR Master Mix, and 3.32 ul DEPC water 
(volume for each reagent is listed per reaction) and was aliquoted (8.7 
ul) into individual wells of a 384-well optical reaction plate using a 
repeat pipetter. The final volume of the master mix was calculated as 
the sum of the total number of reactions plus 10%. 
3. Samples/standards/negative controls (1.3 ul volume) were then added 
to each well, the plate sealed with an optical adhesive cover, then 
centrifuged at 2000 rpm for 2 minutes in a swinging bucket plate 
holder. 
4. The plate was loaded into the Applied Biosystems 7900HT Sequence 
Detector and run with the following program: 
a. Stage 1 (TaqMan hot start): 95°C for 10 minutes 
b. Stage 2 (amplification): 95°C for 15 seconds then 60°C for 1 minute 
(40 cycles) 
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3.3.3 qRT-PCR for GAPDH and snU6 for Normalization of  
         Stem-Loop qRT-PCR Results 
1. For amplification and detection of GAPDH and snU6, qRT-PCR was 
run in triplicate (10 ul reaction volumes) for standards, samples and 
negative controls (see Note 13) using TaqMan Rodent GAPDH Control 
Reagents (Applied Biosystems) or the snU6 primer set (Integrated 
DNA Technologies). 
2. A GAPDH master mix was prepared with 0.1 ul of each forward primer, 
reverse primer, and the probe for rodent GAPDH, 5.0 ul TaqMan 
Universal PCR Master Mix, and 3.7 ul DEPC water (volume for each 
reagent is listed per reaction) and was aliquoted (9ul) into individual 
wells of a 384-well optical reaction plate using a repeat pipetter. The 
final volume of the master mix was calculated as the sum of the total 
number of reactions plus 10%. 
3. A snU6 master mix was prepared with 90 nM snU6 forward and 
reverse primers (0.1 ul of 9 uM forward/reverse working solution; see 
Note 14), 5.0 ul SYBR green and 3.9 DEPC water (volume for each 
reagent is listed per reaction) and was aliquoted (9 ul) into individual 
wells of a 384-well optical reaction plate using a repeat pipetter. The 
final volume of the master mix was calculated as the sum of the total 
number of reactions plus 10%. 
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4. Samples/standards/negative controls (1 ul volume) were then added to 
each well, the plate sealed with an optical adhesive cover, then 
centrifuged at 2000 rpm for 2 minutes in a swinging bucket plate 
holder. 
5. The plate was loaded into the Applied Biosystems 7900HT Sequence 
Detector and run with the following program: 
a. Stage 1: 50°C for 2 minutes 
b. Stage 2: 95°C for 10 minutes 
c. Stage 3: 95°C for 15 seconds then 60°C for 1 minute (40 cycles) 
d. Stage 4: 95°C for 15 seconds, 60°C for 15 seconds, then 95°C for 
15 seconds 
 
3.3.4 Using Modified Oligo(dT) Primer RT Product 
1. For amplification and detection of mature miRNA-132, GAPDH, and 
snU6, qRT-PCR was run in triplicate (10 ul reaction volumes) for 
standards, samples and negative controls (see Note 13) using the 
miScript SYBR Green PCR Kit (Qiagen) and the Mm_miR-132_1 
miScript Primer Assay (Qiagen).  
2. A miRNA-132 master mix consisted of 1ul 10X miScript Universal 
primer, 1 ul 10X miScript miRNA-132 primer, 5 ul 2X Quantitect SYBR 
Green PCR Master Mix (see Note 14), and 1 ul DEPC water (volumes 
for each reagent is listed per reaction) and was aliquoted (9 ul) into 
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individual wells of a 384-well optical reaction plate using a repeat 
pipetter. The final volume of the master mix was calculated as the sum 
of the total number of reactions plus 10%. 
3. A GAPDH master mix was prepared with 0.1 ul of each forward primer, 
reverse primer, and the probe for rodent GAPDH, 5.0 ul TaqMan 
Universal PCR Master Mix, and 3.7 ul DEPC water (volume for each 
reagent is listed per reaction) and was aliquoted (9 ul) into individual 
wells of a 384-well optical reaction plate using a repeat pipetter. The 
final volume of the master mix was calculated as the sum of the total 
number of reactions plus 10%. 
4. A snU6 master mix was prepared with 90 nM snU6 forward and 
reverse primers (0.1 ul of 9 uM forward/reverse working solution; see 
Note 14), 5.0 ul SYBR green and 3.9 DEPC water (volume for each 
reagent is listed per reaction) and was aliquoted (9 ul) into individual 
wells of a 384-well optical reaction plate using a repeat pipetter. The 
final volume of the master mix was calculated as the sum of the total 
number of reactions plus 10%. 
5. Samples/standards/negative controls (1.3 ul volume) were then added 
to each well, the plate sealed with an optical adhesive cover, then 
centrifuged at 2000 rpm for 2 minutes in a swinging bucket plate 
holder. 
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6. The plate was loaded into the Applied Biosystems 7900HT Sequence 
Detector and run with the following program: 
a. Stage 1 (TaqMan hot start):  95°C for 15 minutes 
b. Stage 2 (40 cycles) 
  (Denaturation):  94°C for 15 seconds 
  (Annealing):   55°C for 30 seconds 
  (Extension):   70°C for 34 seconds (see Note 15) 
 
3.3.5 Normalization and Analysis Methods (see Note 16) 
1. ∆∆Ct Method: This method bypasses the need for a standard curve by 
simply using the raw qRT-PCR Ct values. Comparisons can be made 
between a target of interest and a normalizing mRNA as described in 
the formula below (see Note 17). 
 
 
2. Standard Curve Method: Arbitrary values for both miRNA and mRNA 
can be determined by serial diluting cDNA samples produced under 
the same RT conditions to generate a standard curve. Serial dilutions 
are then run simultaneously with the samples. Arbitrary values (formula 
below) determined based on the standard curve (see Note 11). 
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3. Comparisons were made by two-way ANOVA (GraphPad Prism) of the 
stem-loop qRT-PCR (Figure 3-2) or modified oligo dT (Figure 3-3) 
results using the ∆∆Ct and standard curve analyses. 
a. MicroRNA-132 levels measured by stem-loop qRT-PCR normalized 
with GAPDH (Figure 3-2A) and snU6 (Figure 3-2B) were different 
at 4 and 6 hours post-hCG, but there was no significant difference 
between the ∆∆Ct and standard curve analyses.  
b. MicroRNA-132 levels measured by modified oligo(dT) qRT-PCR 
normalized with GAPDH (Figure 3-3A) and snU6 (Figure 3-3B) 
were different at 4 and 6 hours post-hCG, but there was no 
significant difference between the ∆∆Ct and standard curve 
analyses. In contrast, the snU6 normalization detected a difference 
(P<0.05) between the 4 and 6 h time points using the ∆∆Ct analysis 
that was not seen with the other methods/analyses. 
4. Side-by-side comparisons were made by two-way ANOVA (GraphPad 
Prism) of stem-loop versus modified oligo(dT) qRT-PCR ∆∆Ct 
analyzed data normalized with either GAPDH (Figure 3-4A) or snU6 
(Figure 3-4B; see Note 18). 
Method [stem-loop versus modified oligo (dT)] of miRNA-132 quantification 
was not different (P>0.05) for either GAPDH or snU6 normalized data nor was 
there a method by hour interaction. We did observe a trend (P=0.07) for a 
method [stem-loop versus modified oligo (dT)] difference but only in the ∆∆Ct 
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analysis. Although no differences between the two methods were observed, 
the standard error values did appear to be decreased in samples reverse 
transcribed using the modified oligo(dT) RT system. 
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Figure 3-3 
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Figure 3-4 
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4. NOTES 
1. The mature forms of both human and murine miRNA-132, 212 and 30b 
are 100% homologous; therefore, the human primer sets can be used 
to analyze the expression of these mouse miRNA. Data analysis within 
this paper focused on miRNA-132 expression; therefore, qRT-PCR 
data for miRNA-212 and miRNA-30b are not shown. 
2. Individual miRNA specific qRT-PCR primers can be designed and 
substituted for miScript primers within the PCR section of the modified 
oligo(dT) protocol (Qiagen). We have designed our own miRNA-132 
specific primers and observed similar results as provided with primers 
from the kit. It is important to test designed primers for specificity and 
efficiency; in this case, this was done by comparing expression levels 
produced by the designed primer to those produced by the kit primer. 
3. Several kits and reagents are used within the methods described in 
this paper. These products are all provided with extensive protocols 
that include many tips and troubleshooting suggestions. 
4. Glycogen can be added to samples during the RNA isolation process 
to act as a carrier of nucleic acids and will not interfere with RT or PCR 
reactions when used at concentrations lower than 250 ug/ml. For our 
purposes, samples were isolated with 40 ug/ml glycogen, a 
concentration that provides higher RNA yields while remaining well 
below maximum levels.  
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5. RNA samples can be contaminated with proteins, salts and DNA. To 
prevent these types of contamination, extra caution should be taken 
when transferring the aqueous layer during the isolation process. The 
260/280 ratio should be at least 1.8 - 2.0 with lower values suggesting 
high levels of protein within a sample; while a 260/230 ratio below 1.8 
can indicate the presence of organic contaminants including Trizol. 
Although the NanoDrop spectrophotometer is a highly sensitive 
instrument capable of very accurately measuring these ratios as well 
as the RNA concentration using only 1 ul of the sample, any standard 
spectrophotometer can be used to determine absorbance and 
concentration values. 
6. The instructions for the TaqMan MicroRNA Reverse Transcription kit 
suggest a starting amount between 1 and 10 ng of total RNA per 15 ul 
reaction. Following the PCR reaction, this amount of RNA consistently 
yielded high Ct values (i.e. low transcript levels) for miRNA within 
granulosa cells; therefore, we increased the starting amount of total 
RNA to improve the RT reaction and thus produce more robust qRT-
PCR results. 
7. The stem-loop RT method provides a quick, reliable way to measure 
the expression of mature miRNA using a relatively small starting 
amount of RNA. The manufacturer’s protocol provides instructions to 
reverse transcribe one specific miRNA per RT reaction. Our laboratory 
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has determined that it is possible to combine up to 5 RT primers in one 
reaction [120]. To do this, adjustments have been made to the water 
volume, the primer amount and/or the total reaction volume. For the 
stem-loop RT reactions described in this chapter, three specific 
primers were combined (data for miR-132, one of the three miRNA is 
shown). The total volume of the reaction (15 ul reaction) follows the 
manufacturer’s protocol, although the volume of water was adjusted to 
1.16 ul and the amount of each primer was reduced to 2.0 ul of each 
(compared to 3 ul recommended by the manufacturer). A combination 
of either four or five RT primers requires the volume of the RT reaction 
to be increased from 15 ul to 20ul. Volumes of all the reagents change 
accordingly [i.e., 0.2 ul dNTP mix, 1.5 ul Multiscribe, 2.0 ul 10X RT 
buffer, 0.25 ul RNase inhibitor, 3.05 ul (for 4 primers) or 1.05 ul (for 5 
primers) DEPC water, and 2 ul of each primer]. Each RT reaction 
consists of 15 ul of master mix plus 5 ul RNA (50 ng/ul). It is 
important that expression levels of miRNA amplified in a 
combination RT reaction should first be compared to levels 
produced when each miRNA is reverse transcribed alone to make 
sure certain primer combinations do not interfere with each other 
and affect the PCR reaction. 
8. The TaqMan MicroRNA Reverse Transcription kit is designed to 
reverse transcribe only mature miRNA transcripts, therefore 
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normalization to a non-changing (i.e. constitutively expressed RNA) is 
done by performing two separate RT reactions, one for the miRNA and 
one for the normalizer (i.e. GAPDH or snU6) as described in this 
chapter. Of note, we have demonstrated that simultaneous reverse 
transcription of snU6 within the stem-loop primer RT reaction (data not 
shown) provides the same results as compared to two separate RT 
reactions (shown in Figure 3-2). 
9. Remove MMLV reverse transcriptase from freezer right before needed 
and return to the freezer immediately after using it. 
10. One of the added benefits of the miScript Reverse Transcription Kit 
(shown in Figure 3-1) is that both oligo(dT) primers and random 
primers are contained within the RT buffer. Therefore, miRNA and 
mRNA are reverse transcribed within the same tube allowing both 
miRNA and normalizing mRNA from a sample to be analyzed following 
a single RT reaction rather than two separate RT reactions as required 
in the stem-loop RT and miR-Q RT methods. The miScript Reverse 
Transcription Kit is optimized for starting amounts between 10 pg and 
1 ug of total RNA. 
11. Quantitative RT-PCR is only quantitative when the amount of cDNA is 
determined during the exponential doubling phase. Fluorescence is 
measured to establish threshold cycle (Ct) values which represent the 
amount of product amplified at a given point in the reaction. When 
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more template is available at the beginning of the reaction, a fewer 
number of cycles is necessary for the fluorescent signal to measure 
above the background level. Therefore, diluting cDNA will cause an 
increase in the number of cycles needed to reach a given fluorescence 
value. This concept can be used to establish arbitrary fluorescence 
values by creating a standard curve from a serial dilution for a given 
sample set. To do this, an initial stock solution is made from small 
volumes of RT stocks prepared under the same RT conditions. 
Arbitrary values can be assigned to each dilution based on the fold 
differences between each of the dilutions in the series, and a relative 
value for an unknown can be extrapolated by comparing its signal to 
standard curve [115].  
12. The standard curve should be made from samples that are known or 
predicted to have high transcript levels to ensure that the unknown 
sample values will fall within the range of arbitrary values generated by 
the curve.  
13. Negative controls include samples that were not reverse transcribed 
and water blanks.  The absence of fluorescence in non-reverse 
transcribed samples indicates the absence of DNA contamination. We 
typically run non-reverse transcribed negative controls for a single 
miRNA and GAPDH/actin for each sample dilution. If the results are 
negative for genomic contamination for these genes, we make the 
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assumption that the sample is negative for all DNA contamination. 
However, if the laboratory has used transfection agents, like pre-
miRNA, siRNA or expression plasmids for specific genes, a negative 
control should always be run for that specific transcript simultaneously 
with the reverse transcribed sample, as plasmid contamination is a 
major problem for qRT-PCR assays. Water blanks are included to 
confirm the absence of primer dimers (in the case of SYBR green qRT-
PCR) and to confirm that contamination of the PCR product has not 
occurred within the space used to set up the qRT-PCR assays. 
14. PCR primer sets designed without a probe (i.e. snU6 described above) 
rely on SYBR green detection. This dye binds non-specifically to 
double stranded DNA causing the fluorescence signal to increase as 
the amount of double stranded DNA increases. This method of 
measuring fluorescence is vulnerable to primer dimers; therefore, a 
primer check should be performed to determine the highest 
concentration at which the primers can be used without forming 
dimers. The presence of primer dimers can be determined from 
dissociation curve analysis. The melting points for a given primer set 
should all be the same, while the shorter sequence formed by primer 
dimers will melt at a lower temperature which is indicated by a peak 
shift. It is not necessary to perform a primer check when primer sets 
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provided within a kit are used (miScript Primer Assay, Qiagen), as the 
company will provide optimized conditions for each reagent. 
15. The extension time recommended by the miScript System Handbook 
(30 seconds) is optimized for the ABI PRISM 7000 and an adjustment 
to 34 seconds is suggested when using Applied Biosystems 7300 and 
7500 Systems. As an Applied Biosystems 7900HT Sequence Detector 
was used for amplification of our samples, we chose a 34 second 
extension period. 
16. It is not necessary to evaluate data with both ∆∆Ct and standard curve 
analyses. 
17. Normalization is performed to account for variation between unknown 
samples and can be achieved by comparing fluorescent values from a 
gene of interest to those from a gene expressed at a constant level 
within a tissue/cell. The ∆∆Ct data analysis method can be used to 
determine a relative fold-change between samples, but the calculations 
used to determine these values depend on the assumption that the 
PCR reaction is equally efficient for both the transcript of interest and 
that of the normalizer (GAPDH/snU6; [115]). 
18. As there was no significant difference between the ∆∆Ct and the 
standard curve methods (Figures 3-2 and 3-3), only the ∆∆Ct analysis 
is shown in the side-by-side comparison of the two RT methods. 
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Chapter 4 
Transcriptional Regulation of MicroRNA-132/212 
Expression in Murine Periovulatory Granulosa Cells 
 
ABSTRACT 
MicroRNAs (miRNA) are highly conserved, 19-21 nucleotide non-
coding RNAs that bind to the 3`-untranslated region of specific target mRNAs 
to regulate translation. We have recently shown that the mature forms of 
miRNA-132 and miRNA-212 are rapidly (< 2 hours post-hCG) and 
dramatically upregulated (34-fold) in periovulatory mural granulosa cells. 
Moreover, in vitro studies indicated that 8-Br-cAMP treatment of granulosa 
cells mimicked LH-induced in vivo expression of miRNA-132 and 212. These 
two microRNAs share the same seed sequence (a region considered to be 
important in target recognition), and they are located within 203 bases of each 
other in the intron of an uncharacterized gene (AK006051). This study sets 
out to determine the identity of the nascent transcript(s) for miRNA-132 and 
212 within periovulatory granulosa cells and the mechanisms regulating the 
expression of these miRNAs. No significant differences were found in the 
proteins of the miRNA biogenesis pathway (Drosha, DGCR8, Exportin-5 and 
Dicer) over a 12-hr time period following hCG treatment in 19 day old female 
CF-1 mice when analyzed by quantitative RT-PCR (qRT-PCR), suggesting 
that the induction of mature miRNA-132 and 212 occurs as a result of 
increased expression of the miRNA transcript rather than increased miRNA 
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processing. To determine whether these miRNA are co-expressed as a single 
pri-miRNA transcript, a 477 bp pri-miRNA-212/132 transcript was amplified 
with primers designed to span a region 5` to pre-miR-212 through the 3` 
region of pre-miR-132. The single pri-miRNA transcript and similar expression 
profiles of pre-miRNA-132 and 212 suggest that these two miRNA may be 
regulated by a common promoter in mural granulosa cells. Interestingly, 
several CRE sites located 5` to the pre-miRNA sequences have been 
implicated in the regulation of miRNA-132 and 212 expression within the 
neuronal cell line. As both miRNA-132 and 212 pre-miRNA sequences reside 
within the first intron of a gene (AK006051) coding a mRNA transcript of 
unknown function, qRT-PCR primers were designed to span the junction 
between the first and second exons of this gene. Despite the fact that these 
exons do not encode a significant open reading frame, the expression of exon 
1 / 2  and 2 / 3 transcripts were shown to dramatically increased over the 12 
hour time course. Our studies demonstrate that miRNA-132 and miRNA-212 
are coordinately regulated by LH/cAMP. Further studies are necessary to fully 
understand the role of the intronic CRE sites and their interaction with the 
AK006051 promoter. 
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INTRODUCTION 
MicroRNA (miRNA) are highly conserved, 19-21 nucleotide non-coding 
RNAs that bind to the 3`-untranslated region of specific target mRNAs to 
regulate translation. We have recently shown that the mature forms of 
miRNA-132 and miRNA-212 are rapidly (< 2 hours post-hCG) and 
dramatically upregulated (34-fold) in periovulatory mural granulosa cells [120]. 
Moreover, in vitro studies indicated that 8-Br-cAMP treatment of granulosa 
cells mimicked LH-induced in vivo expression of miRNA-132 and 212. These 
two microRNAs share the same seed sequence (a region considered to be 
important in mRNA target recognition), and their pre-forms are located within 
203 bases of each other within the intron of an uncharacterized gene 
(AK006051; Figure 4-1). Additionally, several CRE sites located 5` to the pre-
miRNA sequences have been implicated in the regulation of miRNA-132 and 
212 expression within nerve cells [61]. Interestingly, previous studies within a 
rat neuronal cell line have reported AK006051 to produce a non-coding 
transcript with no significant open reading frame (ORF; [61]). The objectives 
of this study were to first identify nascent transcript(s) for miRNA-132 and 
212, then begin to identify regulatory mechanisms involved with miRNA-
132/212 expression. 
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METHODS AND MATERIALS 
Animals and Granulosa Cell Isolation 
Nineteen-day old CF-1 female mice were injected i.p. with 5IU eCG to 
induce follicular stimulation. After 46 hours, the ovaries were either collected 
(0 hour time point) or the mice were injected i.p. with 5IU of hCG and ovaries 
collected at 1, 2, 4, 6, 8 and 12 hours post-hCG. Periovulatory follicles were 
punctured with a 30-gauge needle and mural granulosa cells were collected 
into PBS. RNA from these granulosa cells was extracted using TRI Reagent 
as per the manufacture’s protocol (Sigma, St. Louis, MO). 
 
Quantitative RT-PCR for Messenger RNAs and Pri-miRNAs 
Intron spanning primers for AK006051 (exons 1 & 2 or 2 & 3) were 
designed using the Primer Express 3.0 software (Applied Biosystems), and 
quantitative RT-PCR (qRT-PCR) was conducted on a 7900 HT Sequence 
Detection System (Applied Biosystems). Each sample was run in triplicate, 
and the ∆∆Ct method was used to calculate relative fold-change values 
between samples. To confirm the existence of a single pri-miRNA-132/212 
that it is transcriptionally upregulated in response to LH, a qRT-PCR primer 
set was designed to amplify a 349 base pair region spanning from the 5’ end 
of the pre-miRNA-212 through the 3’ end of the pre-miRNA-132 (Figure 4-2). 
qRT-PCR to analyze the temporal expression of mature murine miRNA-132 
was performed using a human RT kit and a miRNA assay kit (Applied 
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Biosystems). AK006051 expression was normalized to GAPDH expression 
for all samples using the Rodent GAPDH Taqman primers and probe (Applied 
Biosystems). 
 
 
Amplification and Sequencing of AK006051 
Murine mural granulosa cells were collected four hours post-hCG and 
total RNA isolated as described above. The 5` end of the AK006051 gene 
was identified using a FirstChoice® RLM-RACE (RNA Ligase Mediated Rapid 
Amplification of cDNA Ends) kit (Ambion) in combination with two gene 
specific primers designed to amplify a region through the 5` end of the third 
exon. 
Pre-miRNA-212 Hairpin Pre-miRNA-132 Hairpin
5` 3`
Pri-miRNA-132/212
Forward Reverse
Amplified region shown in red.
 
 
FIGURE 4-2: Primer design for qRT-PCR amplification of pri-miRNA-132/212. 
Dotted lines indicate the positions of the forward and reverse primers. 
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RESULTS 
Temporal Expression of Pri-miR-132/212 in Granulosa Cells In Vivo 
 The in vivo expression pattern for pri-miR-132/212 within mural 
granulosa cells was determined by qRT-PCR. Analysis of pri-miRNA levels 
over the 12 hour periovulatory period indicated the existence of a single pri-
miR-132/212 transcript. This transcript was significantly upregulated at 2 and 
4 hours post-hCG then returned to basal levels by the 6 hour time point 
(Figure 4-3A). The overall expression pattern for pri-miR-132/212 appeared 
to precede the expression levels seen within the mature forms of these 
miRNA (mature miRNA-132 shown inset, Figure 4-3A). Validation of the 
qRT-PCR product done by gel electrophoresis showed an ~349 base pair 
band indicating that the primers amplified a product of the expected size 
(Figure 4-3B). Sequencing of the qRT-PCR product confirmed amplification 
of the expected sequence fragment (data not shown). 
 
Temporal Expression of AK006051 in Granulosa Cells In Vivo 
 The in vivo expression pattern for AK006051 was determined by qRT-
PCR. Analysis of this gene using primers designed to span the junction 
between the first and second exons indicated this transcript to be upregulated 
by 1 hour post-hCG (Figure 4-4A). Expression levels showed a large 
increase over basal levels at 2 and 4 hours post-hCG (~700 and 600-fold 
respectively) and continued to be upregulated through the 12 hour time point. 
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Analysis of AK006051 using a primer set designed to span the second and 
third exons displayed a similar pattern as previously described with 
expression levels upregulated by 1 hour post-hCG, peaking at 2 hours (~300-
fold) post hCG before dropping slightly at 4 hours (~200-fold) post-hCG 
(Figure 4-4B). Transcript levels continued to be upregulated compared to 
basal levels through the 12 hour time point. 
RACE analysis of the 5` end of the AK006051 gene in murine granulosa 
cells indicated two sequencing differences (n=1) compared to the UCSC 
Genome Browser database: 1) Exon 1 was missing ‘GGG’ at the 5` end and 
2) Exon 3 had a single nucleotide change (T  C) at the 29th base. No other 
alternative transcripts were found. 
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Figure 4-3 
FIGURE 4-3: qRT-PCR analysis of pri-miR-132/212 transcript levels (A) in 
mural granulosa cells collected from mice following in vivo treatment with 
eCG for 46 hours (i.e., 0 hour) and eCG + hCG for 1 to 12 hours post-hCG. 
mRNA levels were normalized to GAPDH (mature miRNA-132 expression is 
shown in the inset. (B) qRT-PCR product analyzed by gel electrophoresis. 
Means ± SEM with unlike superscripts (a,b) are different (P<0.05). 
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Figure 4-4 
FIGURE 4-4: qRT-PCR analysis of AK006051 (A) Exons 1/2 and (B) Exons 2/3 
transcript levels in mural granulosa cells collected from mice following in vivo 
treatment of eCG for 46 hours (i.e., 0 hour) and eCG + hCG for 1 to 12 hours 
post-hCG. mRNA levels were normalized to GAPDH. Means ± SEM with unlike 
superscripts (a,b,c,d) are different (P<0.05). 
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DISCUSSION 
The factors and events involved with regulating transcription of miRNA 
are largely unknown. Sequences coding for miRNA can be found in intergenic 
regions of the genome as well as within exons and introns of known genes 
[121]. The diverse nature of their locations suggests that more than one 
mechanism may be involved with miRNA transcription. It has been speculated 
that transcription of intergenic miRNA occurs via promoters specific to these 
particular miRNA, and it remains to be determined whether intronic miRNA 
have their own promoter sequences [122-124] or if they rely upon promoters 
found in the gene within which they are located [124-126]. The dramatic 
increase in AK006051 expression following the LH surge, a finding that 
contrasts with that seen by others in neuronal cells [61], would suggest that 
transcription of miRNA-132 and 212 may be regulated by this gene.  
Our studies demonstrate that miRNA-132 and 212 are coordinately 
regulated by LH/cAMP to produce a single pri-miRNA-132/212 transcript and 
that the gene within which they reside is dramatically upregulated by 2 hours 
post-hCG. Further studies are necessary to fully understand the role of the 
intronic CRE sites and their interaction with the AK006051 promoter. The data 
shown within this chapter represent a starting place for studying the 
transcriptional regulation of miRNA-132 and 212, an event that appears to be 
regulated by the LH surge within periovulatory mouse granulosa cells. 
 97 
Chapter 5 
Conclusions and Future Directions 
 
In the ovary, the follicular granulosa cells provide the proper 
environment (factors) necessary for development of a competent oocyte in 
response to the pituitary hormones, follicle stimulating hormone and 
luteinizing hormone (LH).  Moreover, ovulation of the egg and the subsequent 
luteinization of granulosa cells are dependent on the surge of LH [9, 62]. 
Although much is known about how the genes involved with ovulation and 
luteinization are regulated from a transcriptional level, very little is known 
about how these transcripts are post-transcriptionally regulated prior to being 
translated into a protein. Recently, microRNA (miRNA) have been implicated 
as key players in post-transcriptional gene regulation. Hundreds of unique 
miRNA genes exist in mammals, and each miRNA is postulated to be capable 
of binding to multiple mRNAs, thereby allowing them to act as key regulators 
in a variety of cell processes including differentiation, proliferation and death 
[127, 128]. Following the LH surge, periovulatory granulosa cells undergo a 
rapid and marked differentiation as they convert from proliferative, estrogen 
producing cells to terminally differentiated progesterone producing luteal cells. 
Given the ability of miRNAs to silence the translation of multiple messages 
and the known rapid differentiation process that occurs in periovulatory 
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follicles in response to the LH surge, we speculate that miRNA may play a 
key role in ovarian function.   
As many miRNAs have been shown in other systems to be involved 
with proliferation and cell differentiation, and LH induces differentiation in 
granulosa cells, we are interested in examining the role miRNA play in 
regulating target mRNA(s) following the LH surge. To this end, we have used 
microarray analysis to identify 212 miRNA expressed in murine granulosa 
cells at 0 and 4 hour post-hCG, and  we have demonstrated this to be a 
robust method for identification miRNA expression in the ovary as compared 
to cloning techniques used by others [108]. 
Additionally, we have identified miRNA-132 and -212 as being 
significantly upregulated by LH in granulosa cells. MicroRNA-132 was 
previously implicated in regulating cAMP-induced differentiation of neuronal 
cells [61]. This suggests that miRNA-132 may play a similar role in granulosa 
cell differentiation as it is also a process mediated by cAMP/PKA signaling. 
Interestingly, miRNA-132 and 212 have identical seed sequences suggesting 
they may target similar mRNA(s). Using bioinformatics analysis tools, a 
comparison of potential miRNA-132 and 212 targets to transcripts expressed 
within periovulatory granulosa cells yielded a list of 77 potential mRNA 
targets. Western blot analysis of CTBP1, a putative target of miRNA-132 and 
212, indicated a decrease in protein levels following knockdown of both 
miRNA-132 and 212. CTBP1 has been recently identified as a co-repressor of 
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nuclear receptor genes known to regulate the expression of CYP17 in the 
adrenal cortex [78]. Although CYP17 is not expressed within GCs, CTBP1 
has been shown to interact with steroidogenic factor-1 (SF-1) which is 
expressed by granulosa cells and is associated with regulating genes 
associated with steroidogenesis and maintaining healthy ovarian function 
[129]. This suggests a possible functional role for miRNA-132 in the 
regulation of CTBP1 and the indirect regulation of SF-1 expression in 
granulosa cells. 
The increase in expression of miRNA-132 and 212 following the LH 
surge is the result of an unknown mechanism, but we hypothesize that it is a 
regulated event involving key transcription factors and regulatory elements. 
As previous studies have shown co-expression of clustered miRNAs [130, 
131], we were not surprised that qRT-PCR analysis indicated these two 
miRNAs to be expressed as a single pri-miRNA transcript. This data would 
suggest that miRNA-132 and 212 are regulated by the same promoter. As 
there are CRE sequences upstream of both of these two particular miRNAs, 
the logical place to begin studying their transcriptional regulation is by 
examining the transcription factor CREB. Initial experiments should be 
designed to determine whether LH-induced expression of miRNA-132 and 
212 is a direct result of CREB binding to CRE sites upstream of the miRNA 
sequence and to determine whether CREB preferentially binds at CRE sites 
upstream of miRNA-132 and 212 following LH-induction. 
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Interestingly, previous studies have shown that while intronic miRNAs 
can act as independent transcriptional units [122-124], others rely on the 
transcription of their host gene [27, 124-126]. The pre-forms of miRNA-132 
and 212 both fall within the first intron of the AK006051 gene. Therefore, it is 
entirely possible that transcription of these two miRNA could be regulated by 
the promoter of this gene rather than being under the control of their own 
promoter. Initial qRT-PCR analysis of AK006051 mRNA levels indicated that 
this gene is dramatically upregulated following the LH surge. This would 
suggest a possible ovarian function; therefore, future studies should include 
experiments designed to examine any phenotypic changes that may occur in 
granulosa cells following the over-expression of this transcript. 
Although it is tempting to focus on CREB’s role in regulating miRNA-
132 and 212 expression as the PKA pathway is known to be the main signal 
transduction pathway induced by the LH surge [10, 62], it is possible that 
other cAMP-responsive transcription factors like ATF-1, NF-κB, and CEBP-β 
could potentially be involved. With this in mind, it may be relevant to design 
assays to analyze these transcription factors as well. Moreover, although 
miRNA-132 and 212 are induced following the LH surge and CRE sites are 
positioned near them, these sites may not be involved with promoting the 
transcription of these miRNA. Alternative experiments may focus on other 
DNA elements like Sp1, AP1 and GATA sites that could potentially be 
involved with the expression of these specific miRNAs. 
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In conclusion, we have identified and have begun to characterize two 
of the most highly upregulated miRNA with periovulatory granulosa cells. 
Understanding how these two miRNA regulate translation as well as how they 
are transcriptionally regulated will provide novel information about miRNA 
regulatory mechanism(s) and will begin to shed light on the involvement of 
miRNA within the processes of ovulation and luteinization. 
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